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Abstract
In longitudinal studies it is often of interest to measure the association between a
longitudinal marker repeatedly measured in time and the risk for an event. By postulating
a model for the joint distribution, we acknowledge this link and we can assess the
association between the longitudinal and the survival processes. In this work, we present
the joint modeling approach and focus on the extension of the established methodology
to include sequential survival times and more than one longitudinal variable.
Thus, on the one hand, the purpose of the present work is to introduce the methodology
for the joint models (comparing the frequentist and Bayesian approaches) and to develop
a new theory to include more than one survival time and more than one longitudinal
variable. On the other hand, we study in depth the structure of the R packages that fit
joint models (JM and JMbayes) for one survival time and for one longitudinal variable in
order to give some hints on how they should be modified to implement the problem we
have theoretically formulated.
First of all, we present the methodology for joint modeling for one survival time and
one longitudinal variable from frequentist and Bayesian perspectives and illustrate how
both approaches work with a real case example. Then, this work introduces a new
methodology to deal with a joint model for K > 1 sequential survival times and L > 1
longitudinal variables, taking into account their particularities (such as the possible
correlation that can arise between successive sequential times or between some of the
longitudinal variables). After developing the methodology, we carry out an exhaustive
study of the estimation functions in the two aforesaid R packages, point out their main
differences and present which parts of the implementation should be modified and how
to do it to incorporate K sequential times and L longitudinal variables.
The statistical software R has been used for all computations in this work. The
packages that have been used (among others) are: nlme (Pinheiro et al., 2012), survival
(Therneau, 2013), JM (Rizopoulos, 2013) and JMbayes (Rizopoulos, 2014a).
Keywords: joint models, sequential times, survival analysis, time-dependent covariates.
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Resumen
En estudios longitudinales a menudo el intere´s radica en medir la asociacio´n entre
un marcador longitudinal repetidamente evaluado al largo del tiempo y el riesgo para
un evento. Formulando un modelo para la distribucio´n conjunta, podemos tener en
cuenta esta relacio´n y evaluar la asociacio´n entre el proceso longitudinal y el proceso de
supervivencia. En este trabajo, presentamos una aproximacio´n del tipo joint modeling y
nos centramos en extender la metodolog´ıa existente para incluir tiempos de supervivencia
secuenciales y ma´s de una variable longitudinal.
Por lo tanto, por una parte el objetivo de este trabajo es introducir la metodolog´ıa para
los joint models (comparando las aproximaciones frequentista y bayesiana) y desarrollar
una nueva teor´ıa para incluir ma´s de un tiempo de supervivencia y ma´s de una variable
longitudinal. Por otra parte, se profundiza en el estudio de la estructura de los paquetes
de R que ajustan joint models (JM y JMbayes) para un tiempo de supervivencia y una
variable longitudinal con el objetivo de dar indicaciones sobre co´mo se tendr´ıan que
modificar para implementar el problema que se ha desarrollado teo´ricamente.
Primero de todo, presentamos la metodolog´ıa para el caso de un tiempo de supervivencia
y una variable longitudinal desde puntos de vista frequentista y bayesiano y ilustramos
como funcionan con datos de un ejemplo real. Despue´s, este trabajo introduce la
nueva metodolog´ıa para tratar con un joint model con K > 1 tiempos secuenciales
y L > 1 variables longitudinales, teniendo en cuenta sus particularidades (como la
posible correlacio´n entre tiempos secuenciales sucesivos o entre diferentes variables
longitudinales). Despue´s de desarrollar la metodolog´ıa, llevamos a cabo un estudio
exhaustivo de las funciones de estimacio´n de los paquetes mencionados anteriormente,
sen˜alamos las principales diferencias y detectamos que´ partes de la implementacio´n se
tendr´ıan que modificar y co´mo hacerlo para incorporar K tiempos de supervivencia
secuenciales y L variables longitudinales.
El software estad´ıstico R ha sido utilizado para todos los ca´lculos de este trabajo. Entre
otros, los paquetes usados han sido: nlme (Pinheiro et al., 2012), survival (Therneau,
2013), JM (Rizopoulos, 2013) y JMbayes (Rizopoulos, 2014a).
Palabras clave: joint models, tiempos secuenciales, ana´lisis de la supervivencia, time-
dependent covariates.
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Resum
En estudis longitudinals, sovint interessa mesurar l’associacio´ entre un marcador
longitudinal mesurat al llarg del temps i el risc d’experimentar un cert esdeveniment.
Formulant un model per a la distribucio´ conjunta de les dades longitudinals i les dades
de supervive`ncia, podem tenir en compte aquest relacio´ i avaluar l’associacio´ entre els
dos processos. En aquest treball, presentem l’aproximacio´ de tipus joint modeling i ens
centrem a estendre-la per incloure-hi temps de supervive`ncia sequ¨encials i me´s d’una
variable longitudinal.
Per tant, per una banda, l’objectiu d’aquest treball e´s introduir la metodologia per
als joint models (comparant les aproximacions frequ¨entista i bayesiana) i desenvolupar
una nova teoria per incloure me´s d’un temps de supervive`ncia i me´s d’una variable
longitudinal. D’altra banda, s’aprofundeix en l’estudi de l’estructura dels paquets de
R que ajusten joint models (JM i JMbayes) per a un temps de supervive`ncia i una variable
longitudinal amb l’objectiu de donar indicacions sobre com s’haurien de modificar per
implementar el problema que s’ha formulat teo`ricament.
En primer lloc, presentem la metodologia pel joint modeling d’un temps de supervive`ncia
i una variable longitudinal des dels punts de vista frequ¨entista i bayesia` i il·lustrem
com funcionen les dues aproximacions amb dades d’un exemple real. A continuacio´,
introdu¨ım una nova metodologia per tractar el cas de K > 1 temps de supervive`ncia
sequ¨encials i L > 1 variables longitudinals, tenint en compte les particularitats d’aquest
tipus de dades (com la possible correlacio´ que pot existir entre temps sequ¨encials
successius o entre algunes de les variables longitudinals). Despre´s de desenvolupar la
metodologia, portem a terme un estudi exhaustiu de les funcions d’estimacio´ dels paquets
esmentats anteriorment, assenyalem les principals difere`ncies i presentem quines parts de
la implementacio´ s’haurien de modificar i com fer-ho per incorporar K temps sequ¨encials
i L variables longitudinals.
S’ha utilitzat el software estad´ıstic R per a tots els ca`lculs en aquest treball. Entre d’altres,
els paquets que s’han fet servir so´n: nlme (Pinheiro et al., 2012), survival (Therneau,
2013), JM (Rizopoulos, 2013) i JMbayes (Rizopoulos, 2014a).
Paraules clau: joint models, temps sequ¨encials, ana`lisi de la supervive`ncia, time-
dependent covariates.
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Chapter 1
Introduction and goals
Joint modeling of longitudinal and time-to-event data is an active area of biostatistics that
has received a lot of attention in the recent years mainly because in longitudinal studies
the interest often lies in the relation between a longitudinally measured marker and a time-
to-event outcome. Some examples of this relation are studies on human immunodeficiency
virus (HIV) where we are interested in the association between the longitudinal CD4 cell
count measurements and the time to death (Tsiatis et al., 1995) or prostate cancer studies
in which the practitioner is interested in associating the longitudinal level of prostate
specific antigen (PSA) measurements with the time to cancer recurrence (Proust-Lima
and Taylor, 2009).
One of the main reasons for the increasing interest in this area is that joint models are
applicable in very different situations. For example:
1. When the interest is on the survival outcome and we wish to account for the effect of
a longitudinal variable as a time-dependent covariate. Approaches such as the Cox
proportional hazards model are not applicable when the covariate is endogenous
and time-dependent (Kleinbaum and Klein, 2005). By postulating a model for the
joint distribution, we acknowledge this link and we obtain a more accurate estimate
for the association between the two processes.
2. When the focus is on the longitudinal outcome and we wish to correct for the
potential dropout due to not having longitudinal measurements available at and
after the event time. In order to obtain valid inferences, we need to postulate a
model for the joint distribution of the longitudinal and missingness processes.
In both settings, the joint distribution of the event times and the longitudinal
measurements is modeled through a set of random effects that are assumed to account
for the association between the two outcomes. Both Tsiatis and Davidian (2004) and Yu
et al. (2004) give excellent overviews of this area.
Up to now, most of the work in joint models has focused on models with a single
longitudinal outcome associated with the survival times. However, in many longitudinal
studies, patients are repeatedly measured, generating a series of outcomes that are
potentially predictive for the time until the event. As these longitudinal outcomes are
examples of endogenous time-dependent covariates measured with error, a joint modeling
approach is required. In this regard, there is not much literature on methodologies able to
include in the joint models not one but more than one longitudinal outcomes. Moreover,
1
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it can be also of importance to study the case where each individual has more than one
time to event, that is, when there are two or more events of interest. Although this
situation comprehends different types of data such as sequential, parallel or family data,
in this work we will focus in sequential times. Huertas-Campos (2011) developed the
methodology for the case of two survival times and two longitudinal variables but more
complex cases have not been studied yet.
What we aim in this work is to study the case of not only one survival time and one
longitudinal variable but also the case in which there are more than one survival time
(for example sequential times for each individual) and more than one longitudinal variable
(in order to have more information to help model the time until the event). Moreover,
as the main importance of the theory we develop in this work is its application to real
cases, we take an in depth look to the two main R packages to estimate joint models in
the case of one longitudinal outcome and one event of interest: JM (Rizopoulos, 2010)
and JMbayes (Rizopoulos, 2014a) in order to detect which parts of the code need to be
modified and how to do so to take into account the case for several longitudinal variables
and several time-to-event times.
The purpose of the present work is, then, threefold: on the one hand, after introducing the
methodology for the joint models, we develop a new theory for the case of a joint model
with more than one survival time and more than one longitudinal variable. On the other
hand, we compare the frequentist and Bayesian approaches for estimating the parameters
in these models. Last, we study in depth the structure of the two aforesaid R packages
that are used to estimate joint models with one survival time and one longitudinal variable
in order to understand how they work and give some hints on how they should be modified
to implement an extension of the problem we have theoretically formulated.
The rest of this master’s degree thesis is structured as follows: in Chapter 2, the building
blocks of joint models (relative risk models for survival data, following Cox (1972)
and Kleinbaum and Klein (2005), and linear mixed-effects model for longitudinal data,
following Verbeke and Molenberghs (2000)) are introduced. This chapter also contains a
description of the dataset that motivated the development of a methodology able to work
with several survival times and several longitudinal variables. Chapter 3 introduces the
standard joint model and presents both maximum likelihood and Bayesian estimation.
It also contains an illustration of how packages JM and JMbayes work. In Chapter 4
the methodology for the case of K sequential times and L longitudinal variables, which
will be denoted as JMseq(K,L), is developed. We first study the case of more than one
sequential time and just one longitudinal variable. Then, we focus on one survival time
and introduce more than one longitudinal variable. At the end of this Chapter 4, we arrive
at our main goal which is the study of the case of K sequential times and L longitudinal
variables. The aim of Chapter 5 is to carry out a comprehensive analysis of packages JM
and JMbayes, studying their structure, the similarities and differences between them and
giving indications on how the mentioned packages could be extended for the case of more
than one survival time and more than one longitudinal variable.
The statistical software R has been used for all the computations in this work.
Chapter 2
Longitudinal and survival models
2.1 Introduction
This chapter introduces both the model for the longitudinal data and the model for the
survival data. For the longitudinal information, we construct a linear mixed-effects model
for the analysis of continuous longitudinal responses which is the first building block of
joint models for longitudinal and time-to-event data. We describe the variability that can
be found in a set of longitudinal data and how the parameters of the model are estimated.
Secondly, we introduce the basic concepts for the analysis of survival data as well as
relative risk models. We go through some models for time-to-event data arriving to
the extended Cox Model, the type of relative risk model that constitutes the second
building block for the joint models we are constructing. We focus on the handling of
time-dependent covariates, presenting both endogenous and exogenous covariates.
Because the separate analysis of longitudinal and survival data may lead to inefficient or
biased results, in next Chapter we will model them jointly in order to incorporate all the
information simultaneously.
In order to study the relation between survival times and longitudinal information, at the
end of the Chapter we present the TIBET clinical trial, which is the motivating dataset
for this work. The TIBET clinical trial contemplated the incorporation of interruption
periods in the administration of an intensive therapy for HIV infected patients. The
time that a patient needs before restarting or suspending treatment is of clinical interest.
Because we have the information of previous lifetimes and the evolution of longitudinal
markers, it is plausible to think of a joint model for sequential times to event and
longitudinal information.
2.2 Longitudinal data analysis
Following Verbeke and Molenberghs (2000), correlated data includes several multivariate
structures such as clustered data, spatial correlated data, repeated measurements or
longitudinal data. We will focus on longitudinal data, which can be defined as data
resulting from observations of subjects that are measured repeatedly over time. The
main characteristics of longitudinal data are: 1) the outcome is measured repeatedly
3
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within a set of units, 2) longitudinal measures are positively correlated within subjects,
3) repeated measures from a single subject allow us to capture within-subject patterns
of change and 4) the number of observations and time points can vary from one subject
to another leading to unbalanced longitudinal designs.
With this description, it is clear that in longitudinal setting we expect the repeated
measurements taken on the same subject to be correlated. Thus, standard statistical
tools, such as t-test or simple linear regression, that assume independent observations,
are not appropriate for the analysis of this kind of data.
2.2.1 Variability in longitudinal data
When working with longitudinal data it can not be assumed that measurements are
independent, because as the individuals are followed along time their measurements are
highly likely to be correlated. Thus, when modeling them, we have to take into account
that part of the variability of the data is produced by each individual by itself. Moreover,
because we compare the measurements from different subjects on the population, we have
to take into account the variability between them. Thus, there are two different sources
of variability in longitudinal data:
Between-subject variability
It represents the variation of the subject-specific mean profile with respect to the
population mean profile. This variability is based on the underlying subject-specific
behaviour (due to, for example, genetic or social factors) and how its trend can be derived
from all the repeated measurements that have been recorded.
Within-subject variability
It measures the variability in response within the same subject. This variation is based on
the variability around the subject’s true and unobservable marker, because each marker
can be subject to a potential random measurement error.
In order to illustrate these variabilities, in Figure 2.1 we have the representation of sources
of variability in a balanced study with three individuals and six measurements for each
individual. The black points represent the measurements of the variable of interest at
each time point. They are subject to measurement error since direct observation without
adverse effects is difficult or impossible. The dotted lines stand for the unobservable true
values of the response. The black solid lines represent the subject-specific evolutions,
whereas the red solid line is the population-average evolution.
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Figure 2.1: Sources of variation in longitudinal data. The points are the observations
of the longitudinal response; the dotted lines stand for the true and unknown pattern of
the responses over time for each subject; the solid black lines are the trend lines for each
subject and the solid red line represents the population trend.
2.2.2 The linear mixed model
The idea behind longitudinal data is that each individual of the population has his
own subject-specific mean profile over time. This, coupled with the averaged evolution,
describes the trend of each subject. Thus, in longitudinal data analysis we have:
 Fixed-effects component that captures the average evolution in time of a
variable. This average is an estimate of the evolution of the covariate in the target
population.
 Random-effects component that captures the particular evolution in time for
each of the individuals under study. This part takes into account that the data
from an individual are correlated.
To describe separately the data of each subject, a simple linear regression model with an
intercept and a linear time effect may seem adequate. However, as different subjects might
have different values for intercepts and slopes we must reformulate the model including
random effects in the intercept, the slope or both the intercept and the slope to account
for this variability coming from each subject.
Formally, suppose that we have n subjects, each of them with a different number ni of
measurements of the variable of interest, i = 1, . . . , n. These measurements are taken at
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different time points. Let yij be the response variable of the i-th individual observed at tij,
with i = 1, . . . , n and j = 1, . . . , ni. This tij are called the calendar times. So, for the i-th
subject, its outcomes can be expressed as a ni-dimensional vector yi = (yi1, . . . , yini)
T .
Assuming the longitudinal outcome is normally distributed, the general linear mixed
model can be written as (Laird and Ware, 1982; Verbeke and Molenberghs, 2000):

yi = Xiβ + Zibi + i,
bi ∼ N (0,D),
i ∼ N (0, σ2),
(2.1)
where Xi is the design matrix for the fixed-effects regression coefficients β and Zi is
the design matrix for the random-effects regression coefficients bi. Thus, β denotes the
vector of the unknown fixed effects and bi the vector for the random effects in the model
with D being its covariance matrix. Moreover, i is the random error and σ
2 represents
the within-subject variation. Thus, we assume random effects are normally distributed
with mean zero and variance-covariance matrix D. Moreover, we assume that they are
independent of the error terms i, that is, {b1, . . . bn} independent of {1 . . . , n} and that
errors of an individual are independent between them given bi.
The interpretation of β is the same as in a linear regression model, and bi can be
interpreted as how the regression parameters for the i-th subject deviate from the
population’s parameters.
Estimation of the parameters
The estimation of the parameters of the linear mixed model is based on maximum
likelihood. In particular, for the i-th individual, the marginal density of the observed
data is given by
p (yi) =
∫
p (yi|bi) p (bi) dbi. (2.2)
Because both the conditional distribution of the longitudinal responses given the random
effects and the distribution of the random effects are normal, the integral in (2.2) has a
closed-form solution yi ∼ N (Xiβ,Vi), where Vi = ZiDZTi + σ2Ini . Let α denote the
vector of all variance and covariance parameters found in Vi, that is the elements in D
and the parameters in σ2.
If we assume that α is known, the maximum likelihood estimator of the fixed-effects
vector β can be obtained by the generalized least squares estimator (Laird and Ware,
1982)
β̂ =
(
n∑
i=1
XTi ŴiXi
)−1 n∑
i=1
XTi Ŵyi, (2.3)
where Wi = V
−1
i .
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Estimates for the standard errors of the fixed-effects can be obtained calculating the
variance of the estimator
V̂ar
(
β̂
)
=
(
n∑
i=1
XTi V̂
−1
i Xi
)−1
. (2.4)
Predictions for the subject-specific random effects bi are obtained by the best linear
unbiased predictor (BLUP)
b̂i = D̂Z
T
i V̂i
−1 (
yi −Xiβ̂
)
, (2.5)
where D̂ and V̂i are the restricted maximum likelihood (REML) estimators.
When α is not known, but and estimate α̂ is available, we can set Vi = Vi(α̂) = Ŵ
−1
i
and estimate β by replacing Wi by Ŵi in (2.3). To estimate α, the two frequently
used methods are maximum likelihood estimation and restricted maximum likelihood
estimation.
2.3 Survival Data Analysis
The aim of survival data analysis is to analyse the time until an event of interest occurs.
The response variable, T , is the time until that event, often called survival time or failure
time. The first feature that must be taken into account when working with survival data
is the shape of its distribution. Since event times must be positive, we usually have
skewed shape distributions that make the assumptions on normality do not hold.
Another characteristic that distinguishes survival times is censoring. That means that
the event of interest is not observed on all subjects under study. There are different types
of censoring such as left censoring, right censoring or interval censoring. In this work
we are going to consider only right censoring, that occurs when the subject has not yet
experienced the event of interest at the time when the follow-up period ends. In these
cases, the only information that we have about the true survival time is that it is larger
than the observed survival time.
Denoting T a positive random variable representing the observed survival time, under
the presence of right censoring, each individual provides a true survival time T ∗i and a
right-censored time Ci. With these measures, each individual can be summarized by the
observed survival time Ti = min{T ∗i , Ci} and by the event indicator δi = I (T ∗i ≤ Ci),
thus, for each individual we have its information collected as (Ti, δi).
Considering the skewed shapes and the censoring mechanism, standard statistical tools
cannot be used because they assume that we have complete information, which is not the
case in survival data analysis.
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2.3.1 Basic functions on survival analysis
We assume T ∗ is a continuous random variable that represents the time until some event.
Let F (t) be its cumulative distribution function and f(t) its probability density function.
The interesting functions in survival analysis are:
 The survival function, S(t), which is the probability that the event of interest has
not yet occurred at time t and it is written as
S(t) = P (T ∗ > t) . (2.6)
 The hazard function, h(t), that denotes the rate of occurrence of the event at a
given time t, given that subjects are still at risk, can be written as
h(t) = lim
∆t→0+
P (t < T ∗ < t+ ∆t|T ∗ > t)
∆t
. (2.7)
It can be proved that
h(t) =
f(t)
S(t)
= − d
dt
[log (S(t))]. (2.8)
2.3.2 The proportional hazards Cox Model
The proportional hazards Cox Model (Cox, 1972) gives an expression for the hazard for
an individual at time t with a given set of time-independent explanatory covariates wi
(called baseline covariates) and it can be written as
hi(t|wi) = h0(t)ψ(wi), t ≥ 0, (2.9)
where h0(t) is the baseline hazard function that represents the hazard function when
wi = 0 and is typically left unspecified. Given that wi = (wi1, . . . , wip)
T is a p-dimensional
vector of time-independent covariates for the i-th subject, ψ(wi) is a non-negative function
that contains the information about the effects of the explanatory covariates for the i-th
subject. Usually, we take ψ(wi) = exp(γ
Twi), where γ = (γ1, . . . , γp)
T is an unknown
p-dimensional parameter vector. So, the expression (2.9) becomes
hi(t|wi) = h0(t) exp{γ1wi1 + · · ·+ γpwip} = h0(t) exp
{
p∑
k=1
γkwik
}
. (2.10)
This model is called proportional hazards model because if we consider two subjects i
and j with covariates wi and wj, their hazard ratio is constant and given by
h (t|wi)
h (t|wj) =
h0(t) exp {
∑p
k=1 γkwik}
h0(t) exp {
∑p
k=1 γkwjk}
= exp
{
p∑
k=1
γk (wik − wjk)
}
, (2.11)
and, therefore, their hazard rates are proportional and are not time-dependent.
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2.3.3 Extended Cox Model for time-dependent covariates
The relative risk model that we have introduced assumes that the hazard depends only
on baseline covariates whose values are constant during follow-up. However, in many
studies the interest can be in studying whether time-dependent covariates are associated
with the risk of experimenting the event. Before explaining how this covariates need to
be handled, we are going to distinguish between two different types of time-dependent
covariates, endogenous (or internal) and exogenous (or external). The need for this
distinction is that the endogenous variables require special treatment compared to the
exogenous ones.
Types of time-dependent covariates
Denoting yi(t) the time-dependent covariates at time t for the i-th individual, and
Yi(t) = {yi(s), 0 < s ≤ t} the covariate history for this individual up to time t, there are
two types of time-dependent covariates
1. External or exogenous covariates: following Kalbfleisch and Prentice (2002), these
are covariates that satisfy the relation
P (s ≤ T ∗i < s+ ds|T ∗i ≥ s,Yi(s)) = P (s ≤ T ∗i < s+ ds|T ∗i ≥ s,Yi(t)) , (2.12)
for all s, t such that 0 < s ≤ t and ds→ 0. An exogenous covariate is a predictable
process, so its value at any time t is known infinitesimally before t. In other words,
its future path up to time t > s is not affected by the occurrence of failure at time
s. An example of an exogenous covariate is the time of the day or the season of
the year. Another type of external covariates are processes external to the subject
under study. For instance, the level of air pollution, that may be associated with
the frequency of asthma attacks. For external covariates, we can use the relation
between the survival function and the hazard function to directly define the survival
function conditional on the covariate as follows
Si (t|Yi(t)) = P (T ∗ > t|Yi(t)) = exp
{
−
∫ t
0
hi (s|Yi(s)) ds
}
. (2.13)
2. Internal or endogenous covariates: this are covariates that arise when there are
time-dependent measurements taken on the subjects under study. The change of the
covariate depends on the individual. This type of covariates are usually measured
with error and it is reasonable to assume that the observed marker levels are a
contaminated version of the true marker levels. Examples of endogenous covariates
include biomarkers such as CD4 cell counts for HIV-infected patients or serum
bilirubin levels for patients with primary biliary cirrhosis.
Extended Cox Model
Proportional hazards (PH) model assumed that the value of covariates is constant over
time. However, relevant covariates for survival analysis may change in the observation
period. Following Kleinbaum and Klein (2005), we can write the extended Cox Model to
handle both time-independent and time-dependent covariates.
If yi(t) is the covariate at time t for the i-th subject, Yi(t) = {yi(s), 0 ≤ s ≤ t} is the
covariate history until t and wi = (wi1, wi2, . . . wip)
T is the vector of baseline covariates
for the i-th subject then the extended Cox Model can be written as
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hi (t|Yi(t),wi) = h0(t) exp{γTwi + αyi(t)}. (2.14)
In a similar way as in the PH Cox Model, the extended model contains a baseline hazard
function multiplied by an exponential part. However, in the extended Cox Model, the
exponential part contains both time-independent and time-dependent predictors. In this
model the regression coefficients γ and α have the same interpretation as the coefficients
in the proportional hazards Cox Model.
Despite having more flexibility than the PH Cox Model, the extended Cox Model is not
appropriate when the time-dependent covariates are endogenous variables, because for
these variables we do not have the complete knowledge of the covariate history for all
individuals while on study. In the extended Cox Model time-dependent covariates are
assumed to change its value at follow-up visits and to remain constant in the interval
between them. This assumption is unrealistic when having endogenous covariates, such
as biomarkers, because it is not reasonable to think they remain constant between
measurement points. This assumption lead to biased estimations. As a consequence,
it is necessary to introduce a modeling framework to deal with the special features of
endogenous time-dependent covariates.
2.4 Motivating dataset: The TIBET clinical trial
TIBET was a clinical trial carried out by the Fundacio´ Lluita contra la Sida at Hospital
Germans Trias i Pujol of Badalona (Spain) that contemplated the incorporation of
interruption periods in the administration of HAART (Highly Active AntiRetroviral
Therapies) for HIV infected patients (Ruiz et al., 2007). The aim of the study was to
analyze the time that a patient needs before restarting or suspending treatment given the
values of biological markers recorded in the follow-up period. This clinical trial motivated
the proposal of a joint model to analyze sequential times to event with more than one
longitudinal variable.
Patients who entered the study were randomized to continue the HAART therapy
(n = 101) or to follow a protocol of treatment-interruption (n = 100). Patients who went
under the treatment-interruption protocol started with suspension of treatment (stage
OFF) and every four weeks information on CD4 cell counts (which are cells that send
signals to activate the body’s immune response) and viral load (which is the level of HIV
in a patient’s blood) was registered. If the conditions of the patient had deteriorated, the
therapy was restarted (stage ON). In Figure 2.2 we can see different cycles of treatment
recorded in the study. Patients in the control group received standard HAART during
the follow-up, whereas subjects interrupting therapy could experiment different number
of OFF-ON and ON-OFF changes. Numbers at the right of the figure represent the
number of patients according to the interruption-reinitation sequence.
Therefore, the treatment generates a sequence of stages OFF-ON-OFF-ON that defines
a sequence of times T1, T2, . . . , TK that are the length that a patient stays on each stage.
That means that T1 is the duration of the first stage OFF (time, from randomization, that
a patient stays without therapy), T2 is the duration of the first stage ON (or, equivalently,
the time since the patient starts treatment until he is switched off) and T3 will be the
second time OFF (the time the patient is without treatment for the second time). This
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{Ti : i = 1, . . . , K} occur sequentially and in order, meaning that transition l (moving
from stage OFF to stage ON or vice versa) only occurs after the previous l−1 transitions
have occurred. One of the goals of this type of clinical trial was to characterize the time
spent in the first state ON (T2) taking into account the information of the first state OFF
(T1).
Together with these times, there were records of the CD4 cell count and of the viral
load for each patient along time. These two biological markers can be the longitudinal
variables included in the joint model for modeling the survival times with more than one
longitudinal variable. First of all we need to model them along T1 and T2 (or T1, . . . , TK
if we extend the case to K sequential times). This longitudinal information can follow
different trends such as linear, parabolic or piecewise.
Figure 2.2: Profiles of treatment interruption and reinitiation during the TIBET study.
The patients followed different cycles of treatment withdrawal (black) and reinitiation
(white). Source: Ruiz et al. (2007).
The conditions for reinitiating the therapy (moving from stage OFF to stage ON) were
either
 The CD4 levels decrease to less than 350 cell/mm3.
 The viral load increases to more than 100000 copies/ml.
 Development of an AIDS-defining event.
Analogously, a patient moved from stage ON to stage OFF (suspending the therapy)
when the two following conditions held
 The CD4 levels reach more than 500 cell/mm3.
 The viral load decreases to undetectable levels (such as less than 50 copies/ml).
In Figure 2.3 we can see the evolution of the CD4 levels and the viral load for one
particular subject who followed the protocol of treatment-interruption. Note that we
have represented the square root of the CD4 cell counts and the logarithm of the viral
load because these are the transformed variables that we will include in our models.
Jointly with the evolution of the longitudinal variables we can see the changes in stages
ON and OFF. We observe that in ON periods, the CD4 cell counts go up and the viral
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load goes down. The opposite happens in OFF stages. Moreover, we have represented
the limit values for reinitiating and suspending treatment for both CD4 and viral load.
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Figure 2.3: Evolution of
√
CD4 and log (viral load) for a particular subject jointly with
the sequence of stages ON-OFF. The solid lines stand for the conditions for reinitiating
treatment (green ones) and interrupting treatment (red).
In this case, and because a latent association between survival and longitudinal variables
existed, a joint model must be fitted in order to estimate properly both processes and
thus, since we have sequential times and two longitudinal variables, a joint model for
sequential times to event and more than one longitudinal variable is needed.
Chapter 3
Joint modeling framework
3.1 Introduction
The motivating idea behind the joint models is to couple survival data, which is of
primary interest, and a suitable model for the repeated measurements of the endogenous
covariate. Joint models were introduced during the 90’s (Tsiatis et al., 1995; Faucett and
Thomas, 1996; Wulfsohn and Tsiatis, 1997) and since then they have been applied to a
lot of studies in epidemiological and biomedical areas. Recently, Rizopoulos has made a
great contribution to the joint modeling methodology, first by an overview of the theory
and applications of joint modeling (Rizopoulos, 2012) and secondly by developing the
JM (Rizopoulos, 2010) and JMbayes (Rizopoulos, 2014a) R packages for the frequentist
and Bayesian approaches, respectively. In this line, joint modeling also illustrates how
frequentist and Bayesian statistics can be combined to reach a complex goal, using the
strengths of both approaches.
In this Chapter, based on the linear mixed-effects model and the relative risk model
introduced in Chapter 2, we present the standard joint model for longitudinal and survival
data. A typical joint model setting is to assume a linear mixed-effects model for the
longitudinal covariates and a Cox model or an accelerated failure time model for the
survival data, with the two models sharing some random effects or covariates.
We discuss also maximum likelihood estimation of the parameters from the frequentist
and Bayesian points of view.
3.2 Longitudinal submodel
Because the longitudinal covariate is an endogenous time-dependent covariate that we
have measured with error, we assume that the observed value of the longitudinal covariate
yi(t) equals the true and unobserved level of the endogenous variable at time t, mi(t),
plus a random error term, i(t). If Mi(t) = {mi(s), 0 ≤ s < t} is the history of the
unobserved longitudinal process until t, we need to estimate mi(t) and reconstruct the
complete longitudinal history Mi(t) for each subject.
To describe the subject-specific time evolutions, we focus on normal data and use a linear
mixed-effects model as
13
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
yi(t) = mi(t) + i(t),
mi(t) = x
T
i (t)β + z
T
i (t)bi,
bi ∼ N (0,D),
i(t) ∼ N(0, σ2).
(3.1)
We should note that in (3.1), both the design vector xi(t) for the fixed effects β and
the design vector zi(t) for the random effects bi as well as the error term i(t) are time-
dependent. This time structure and the use of subject-specific random effects allows us
to reconstruct the complete path of the time-dependent process Mi(t).
Moreover, as in the previous Chapter, we assume that error terms are mutually
independent, independent of the random effects and normally distributed with mean
zero and variance σ2.
3.3 Survival submodel
To quantify the relation between mi(t) and the risk for an event at time t, we postulate
a relative risk model for t > 0
hi(t|Mi(t),wi) = h0(t) exp{γTwi + αmi(t)}, (3.2)
where, as we have said before, mi(t) is the true and unobserved value of the longitudinal
(endogenous) variable at time t and Mi(t) is the history of the unobserved longitudinal
process until t. To quantify the association between the true marker levels and the risk
for an event we use α. The baseline risk function is represented by h0(t), wi is the vector
of baseline covariates for the i-th subject and γ its corresponding vector of regression
coefficients.
In survival analysis, the baseline risk function h0 is typically left unspecified, but in the
joint modeling framework leaving this function unspecified leads to an underestimation of
the standard error of the parameter estimates (Hsieh et al., 2006). Hence, to avoid these
problems, to complete the definition of the model is necessary to discuss the choice for h0.
We could use a hazard function corresponding to a known parametric distribution such as
the ones typically used in the context of survival analysis, Weibull, Gamma or log-normal.
Alternatively, we can use a parametric but flexible specification such as step-functions
and linear splines (Whittemore and Killer, 1986), B-splines approximation (Rosenberg,
1995) or restricted cubic splines (Herndon and Harrel, 1996). We formalize here two of
the options, that are simple and work satisfactorily in practice: the piecewise-constant
model and the regression splines approach.
For the piecewise-constant model, the baseline risk function takes the form of
h0(t) =
Q∑
q=1
ξqI (νq−1 < t < νq) , (3.3)
where 0 = ν0 < ν1 < · · · < νQ is a split of the time scale (with νQ being larger than the
largest observed time) and ξq denotes the value of the hazard in the interval (νq−1, νq) .
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For the regression splines model, the logarithm of the baseline risk function is expanded
into B-splines basis functions for cubic splines and can be expressed as
log h0(t) = γh0,0 +
Q∑
q=1
γh0,qBq(t, ν), (3.4)
where Bq(t,v) denotes the q-th basis function of a B-spline with knots ν = (ν1, . . . , νQ)
and γh0,0 is the vector of spline coefficients. Note that when the number of knots increases,
the specification of the baseline hazard becomes more flexible.
In both approaches, after the number of knots have been chosen, their location is typically
based on percentiles of either the observed event times (Ti = min(T
∗
i , Ci)) or only the
true event times ({Ti : T ∗i ≤ Ci, i = 1, . . . , n}) to allow for more flexibility in the region
with greatest density.
In fact, as we will see in Chapter 5, these two options that we have formalized are the
options by default when using packages JM and JMbayes (piecewise for JM and regression
splines for JMbayes).
3.4 Joint Model formulation
Taking into account the two submodels we have defined and explained in previous sections
and their particularities, following Rizopoulos (2012) we are going to build the joint model
by joining the two submodels, as follows
{
yi(t) = mi(t) + i(t) = x
T
i (t)β + z
T
i (t)bi + i(t)
hi(t|Mi(t),wi) = h0(t) exp{γTwi + αmi(t)}. (3.5)
With this formulation, the hazard at age t for the i-th individual, with a true longitudinal
profile Mi(t) up to time t, can be expressed as
hi(t|Mi(t),wi) = h0(t) exp{γTwi + α
(
xTi (t)β + z
T
i (t)bi
)}. (3.6)
3.5 Joint Model estimation
The main estimation methods proposed for joint models are maximum likelihood
(Henderson et al., 2000; Hsieh et al., 2006; Wulfsohn and Tsiatis, 1997) and the Bayesian
approach using MCMC techniques (Brown and Ibrahim, 2003; Chi and Ibrahim, 2006;
Wany and Taylor, 2001).
Maximum likelihood approach
Maximum likelihood estimation for joint models is one of the most traditional approaches
and is based on the maximization of the log-likelihood corresponding to the joint
distribution of the time-to-event and the longitudinal outcomes, that can be written
as {Ti, δi,yi}. Note that we have omitted covariates wi to ease the notation. In order to
Chapter 3. Joint modeling framework 16
define this distribution, we will assume that the vector of random effects bi underlies both
the survival and longitudinal processes (so, in this case, random effects account for both
the correlation between measurements in the longitudinal outcome and the association
between the longitudinal and event outcomes). In other words, we are assuming that
survival times and longitudinal covariates are independent given the random effects. We
can write
p (Ti, δi,yi|bi;θ) = p (Ti, δi|bi;θ) p (yi|bi;θ) (3.7)
p (yi|bi;θ) =
∏
j
p{yi (tij) |bi;θ} (3.8)
where θ =
(
θTt ,θ
T
y ,θ
T
b
)T
is the parameter vector, with θt denoting the parameters for
the survival outcome, θy the parameters for the longitudinal outcome and θb the unique
parameters of the random-effects covariance matrix. Moreover, yi denotes the vector of
the ni longitudinal outcomes for the i-th subject and p (·) is an appropriate probability
density function.
Under the conditional independence assumptions and using (3.7) and (3.8), the joint
log-likelihood contribution for the i-th subject can be formulated as
log p (Ti, δi,yi;θ) = log
∫
bi
p (Ti, δi|bi;θt,β)
[∏
j
p{yi (tij) |bi;θy,β}
]
p (bi;θb) dbi,
(3.9)
where p{yi (tij) |bi;θy,β} is the univariate normal density for the longitudinal responses
and p (bi;θb) is the multivariate normal density for the random effects and the likelihood
of the survival part is written as
p (Ti, δi|bi;θt,β) = [hi (Ti|Mi (Ti) ;θt,β)]δi Si (Ti|Mi (Ti) ;θt,β) =
[hi (Ti|Mi (Ti) ; θt,β)]δi exp
{
−
∫ t
0
hi (s|Mi(s); θt,β) ds
}
, (3.10)
The maximization of the log-likelihood function (3.9) with respect to θ is a computa-
tionally challenging task mainly because the integrals in (3.9) and (3.10) do not have
analytical solutions, except in very special cases. From the two integrals, the one with
respect to the random effects is the main computational bottleneck. The integral in
the definition of the survival can be relatively efficiently approximated using 7-point or
15-point Gauss-Kronrod rule. However, the integral in (3.9) with respect to the ran-
dom effects becomes computationally demanding to approximate as its dimensionality
increases (Rizopoulos, 2012). Standard numerical integration techniques such as Gaus-
sian quadrature rules and Monte Carlo sampling have been successfully applied in the
joint modeling framework but still remain relatively computationally demanding. For the
maximization of the log-likelihood function l(θ) =
∑
i log p (Ti, δi,yi;θ) with respect to
θ, the Expectation-Maximization (EM) algorithm has been traditionally used (Dempster
et al., 1977).
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Bayesian approach
Under the Bayesian approach, estimation of the parameters of the joint model is done
using Markov chain Monte Carlo (MCMC) algorithms. In a similar way as in the
likelihood estimation we have
p (Ti, δi,yi|bi;θ) = p (Ti, δi|bi;θ) p (yi|bi;θ) (3.7)
p (yi|bi;θ) =
∏
j
p{yi (tij) |bi;θ}. (3.8)
Under the assumptions we have already presented, the posterior distribution is analogous
to
p (θ,b|Ti, δi,yi) =
n∏
i=1
ni∏
j=1
p (yi (tij) |bi,θ) p (Ti, δi|bi,θ) p (bi,θ)
p (Ti, δi,yi)
∝
n∏
i=1
ni∏
j=1
p (yi (tij) |bi,θ) p (Ti, δi|bi,θ) p (bi,θ) p (θ) , (3.11)
where
p (yi (tij) |bi,θ) = exp
{
[yi (tij)ψij (bi)− c {ψij (bi)}]
a (ϕ)
− d (yi (tij) , ϕ)
}
, (3.12)
with ψij (bi) and ϕ denoting the natural and dispersion parameters in the exponential
family, respectively, c (·), a (·) and d (·) being known functions specifying the member of
the exponential family. For the survival part we have
p (Ti, δi|bi,θ) = [hi (Ti|Mi (Ti))]δi Si (Ti|Mi (Ti))
= [hi (Ti|Mi (Ti))]δi exp
{
−
∫ Ti
0
hi (s|Mi (s)) ds
}
, (3.13)
and the integral in the definition of the survival function in (3.13)
Si (t|Mi (t) ,θ) = exp
{
−
∫ t
0
h0 (s) exp [αmi (t)] ds
}
(3.14)
does not have a closed-form solution and, hence, a numerical method should be employed
for its computation.
3.6 Joint Model illustration: TIBET
In this section we are going to apply the joint modeling techniques to a particular case
study, the TIBET clinical trial. In the TIBET study there are two observed longitudinal
outcomes for a each patient at time t, CD4 cell counts and viral load. As stated before,
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we are interested in the survival outcome and we wish to account for the effect of a
longitudinal variable as a time-dependent covariate. Thus, we are going to fit joint
models separately for time until treatment reinitation (T1) and time until treatment
interruption (T1 + T2). Since we can not include two longitudinal variables in the fitting
of a joint model through packages JM and JMbayes, we have fit joint models separately
for CD4 cell counts and for viral load. When fitting joint models, we use
√
CD4 and the
logarithmic transformation of viral load to obtain linearity and to have a similar range
of values in both variables. A choice that we have to make before fitting the models is
the approximation of the log baseline hazard function. We have chosen to approximate
it with splines, because it is the only common option in both packages and it allows to
compare the results.
3.6.1 Models for time to treatment reinitiation T1
We proceed by fitting joint models to study the time until treatment reinitiation with
information from the longitudinal variables.
To study the time to reinitation (T1) adjusting for the longitudinal variable
√
CD4,
we have fitted a joint model using as a baseline covariate for the survival part the
information on the logarithm of the viral load that the patient had before entering the
study (log(VLpret)). For the longitudinal submodel, we are assuming a model with
random intercept and random slope. The following joint model was fitted:
{ √
CD4i (t) = mi (t) + εi (t) = (β0 + bi0) + (β1 + bi1) t+ i (t)
hi(t|Mi(t),wi) = h0(t) exp{γlog (VLpret) + αmi(t)}, (3.15)
where bi ∼ N2 (0,D) and i (t) ∼ N (0, σ2ε) with D being an unstructured 2 x 2 matrix
for the random effects.
Parameter estimates can be found in Table 3.1 along with their 95% confidence intervals
(for jointModel()) and credibility intervals (for jointModelBayes()). We can see that
estimations from both packages are quite similar. In this regard, both show no correlation
between the random effects (confidence and credibility intervals for ρb0b1 both contain
zero) and a negative value for the association parameter α. Thus, the CD4 cell counts
(expressed as
√
CD4) have a slightly negative association with the risk of reinitiating
therapy, a result that points in the direction of what we have already explained, that
high levels of CD4 lengthen the time until treatment reinitiation.
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Table 3.1: Joint models for time to reinitation (T1) adjusting for the longitudinal variable√
CD4: parameter estimates, confidence and credibility intervals and AICs and DICs
JM JMbayes
Parameters Estimate 95% CI Estimate 95% Cred. Int.
Longitudinal submodel
β0 26.67 (25.91, 27.43) 27.38 (26.85, 27.84)
β1 -0.12 (-0.13,-0.11) -0.15 (-0.17, -0.12)
σb0 4.11 (3.50, 4.72) 4.33 (3.71, 5.02)
σb1 0.09 (0.09, 0.09) 2.08 (1.81, 2.41)
ρb0b1 0.11 (-0.13, 0.44) -0.12 (-0.26, 0.11)
σε 2.3 (2.21, 2.39) 2.16 (2.08, 2.24)
Survival submodel
γ 0.55 (0.17, 0.93) 1.01 (0.75, 1.29)
Association
α -0.29 (-0.38, -0.19) -0.33 (-0.39, -0.27)
Goodness of fit
AIC / DIC 8198 8479
Restricted maximum likelihood estimates in the JM case. AIC represents the Akaike
information criterion, DIC stands for the deviance information criterion, CI stands
for confidence interval and Cred. Int. means credibility interval. The survival model
considers log(VLpret) as a covariate.
To study the time to reinitation (T1) adjusting for the longitudinal variable log (VL), we
have fitted a joint model including in the survival submodel the information given by CD4
nadir (
√
CD4N), which is the lowest level of CD4 that subjects have ever had. In this
scenario, we have chosen to include only random intercept in the survival model because
when including also the random slope, the Bayesian approach did not converge for σb1
and ρb0b1 . Therefore, the following joint model was fitted:{
log VLi (t) = mi (t) + εi (t) = (β0 + bi0) + β1t+ i (t)
hi(t|Mi(t),wi) = h0(t) exp{γ
√
CD4N + αmi(t)}, (3.16)
where bi ∼ N
(
0, σ2b0
)
and i (t) ∼ N (0, σ2ε).
Estimation of the parameters and confidence and credibility intervals can be found in
Table 3.2. We observe that although estimates for the parameters in the longitudinal
and survival submodels are almost the same for packages JM and JMbayes, this is not the
case for the estimate for the association between both processes. Whereas the frequentist
approach reports a non significant association between longitudinal and survival processes,
the Bayesian one acknowledges this link (although it reports an estimate close to zero).
This can be due to a lack of converge in the Bayesian approach and running more iterations
might lead to an estimate closer to the one in the frequentist approach.
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Table 3.2: Joint models for time to reinitation (T1) adjusting for the longitudinal variable
log (VL): parameter estimates, confidence and credibility intervals and AICs and DICs
JM JMbayes
Parameters Estimate 95% CI Estimate 95% Cred. Int
Longitudinal submodel
β0 3.88 (3.76, 4.007) 3.89 (3.77, 4.02)
β1 0.006 (0.005, 0.007) 0.006 (0.005, 0.008)
σb0 0.51 (0.34, 0.68) 0.56 (0.48, 0.63)
σε 0.79 (0.76, 0.82) 0.79 (0.76, 0.82)
Survival submodel
γ -0.13 (-0.17, -0.08) -0.13 (-0.17, -0.10)
Association
α 0.49 (-0.21, 1.18) 0.29 (0.06, 0.50)
Goodness of fit
AIC / DIC 4515 4592
Restricted maximum likelihood estimates in the JM case. AIC represents the Akaike
information criterion, DIC stands for the deviance information criterion, CI stands
for confidence interval and Cred. Int means credibility interval. The survival model
considers
√
CD4N as a covariate.
3.6.2 Models for time to treatment interruption T1 + T2
In the same way as we did for time to treatment reinitiation, we are going to fit models for
the time until treatment interruption with information from the longitudinal covariates.
The models are basically the same ones as fitted for T1, but keeping in mind that we are
now modeling the time from the first treatment interruption until the second.
The results for the time to withdrawal adjusting for the longitudinal
√
CD4 using the
level of viral load pretherapy as a baseline covariate for the survival part can be found in
Table 3.3. We can see that the coefficient for the baseline covariate log (VLpret) is non
significant in both estimations. For the coefficient correlation between random effects,
both functions report intervals containing zero suggesting independent random effects.
The packages give very different estimations for σb1 . It is plausible that, although package
JM gives an estimation, in reality the coefficient is non identifiable and for this reason
JMbayes does not converge. The Bayesian estimation reports an association coefficient
non significant whereas in the frequentist one it is significant (but very close to zero).
It is important to note that the model does not capture the relation between time to
withdrawal and the longitudinal CD4 cell counts. This can be due to either the modeling
of the cummulative time T1 + T2 until treatment interruption instead of the depending
censored gap time T2 or the limitation of not being able to include both longitudinal
covariates at the same time.
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Table 3.3: Joint models for time to withdrawal (T1 + T2) adjusting for the longitudinal
variable
√
CD4: parameter estimates, confidence and credibility intervals and AICs and
DICs
JM JMbayes
Parameters Estimate 95% CI Estimate 95% Cred. Int
Longitudinal submodel
β0 24.08 (23.16, 24.98) 24.18 (23.46, 24.89)
β1 0.0002 (-0.01, 0.01) -0.02 (-0.06, 0.02)
σb0 3.66 (2.97, 4.35) 3.64 (2.98, 4.35)
σb1 0.04 (0.04, 0.04) 4.17 (3.51, 4.95)
ρb0b1 -0.32 (-0.62, 0.074) 0.0002 (-0.17, 0.37)
σε 2.73 (2.62, 2.84) 2.72 (2.61, 2.84)
Survival submodel
γ 0.32 (-0.07, 0.72) -0.19 (-0.54, 0.14)
Association
α 0.08 (0.007, 0.16) 0.0006 (-0.09, 0.08)
Goodness of fit
AIC / DIC 7004 7530
Restricted maximum likelihood estimates in the JM case. AIC represents the Akaike
information criterion, DIC stands for the deviance information criterion, CI stands
for confidence interval and Cred. Int means credibility interval. The survival model
considers log(VLpret) as a covariate.
To model time to withdrawal adjusting for the longitudinal variable log (VL), we have
fitted the same joint model as when we were modeling time to reinitiation.
Results for the parameter estimates and its confidence and credibility intervals can be
found in Table 3.4. Both of them produce a similar fit. The association parameter is
negative in both cases (α = −0.87 for JM and α = −1.17 for JMbayes), showing that
an increase in the viral load decreases the risk to withdrawal, i.e. if the viral load of an
individual increases, its time until treatment withdrawal will be longer.
In all these models we could only include one of the longitudinal variables and, thus,
the information about the relationship between them could not be taken into account.
Therefore, there is the necessity to develop a methodology to include more than one
longitudinal variable in the predictor of the survival model. Moreover, because sequential
survival times can be related (and they often are) it is also of importance to include them
together in the model and use the information of their correlation. In the next Chapter
we develop a methodology that allows to include in the joint model information on more
than one longitudinal variable and more than one sequential survival time.
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Table 3.4: Joint models for time to withdrawal (T1 + T2) adjusting for the longitudinal
variable log (VL): parameter estimates, confidence and credibility intervals and AICs and
DICs
JM JMbayes
Parameters Estimate 95% CI Estimate 95% Cred. Int
Longitudinal submodel
β0 3.81 (3.65, 3.98) 3.82 (3.64, 4.005)
β1 -0.02 (-0.02, -0.016) -0.019 (-0.02, -0.01)
σb0 0.55 (0.32, 0.78) 0.62 (0.51, 0.75)
σε 1.14 (1.10, 1.19) 1.15 (1.10, 1.19)
Survival submodel
γ -0.07 (-0.13, -0.005) -0.08 (-0.14, -0.02)
Association
α -0.87 (-1.51, -0.24) -1.17 (-1.75, -0.62)
Goodness of fit
AIC / DIC 4575 4575
Restricted maximum likelihood estimates in the JM case. AIC represents the Akaike
information criterion, DIC stands for the deviance information criterion, CI stands
for confidence interval and Cred. Int means credibility interval. The survival model
considers
√
CD4N as a covariate.
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4.1 Introduction
The majority of the joint models developed so far in the statistical literature focus on
univariate time-to-event data. Chi and Ibrahim (2006) presented a model for multivariate
longitudinal and multivariate survival data (but in that case the survival times were
parallel and not sequential as the ones we aim to study in this work) and Liu and Huang
(2009) studied a repeated measures process and a recurrent event process subject to a
dependent terminal event (for example, higher CD4 cell counts are associated with lower
risk of recurrent opportunistic diseases, both correlated with mortality). However, and
although there are many potential applications, there is not much literature on the jointly
modelization of longitudinal data with several types of failure time random variables, such
as time to cancer relapse at two different organs, time to cancer relapse and death, time
to first and second infection or, such as in the TIBET case, time without treatment and
time with treatment.
In this kind of studies, where two, or more, consecutive times are observed and the
censoring acts on their sum, the estimation of the joint survival function of the first time
(T1) and the second (T2) has to take into account that T2 is only observed if T1 + T2
does not exceed the total time of follow-up. Thus, the censoring mechanism acting on T2
will depend on T1. Because these variables are typically correlated, it is of great interest
to examine their joint association with longitudinal markers. Hence it is important to
develop a multivariate survival model capable of linking relevant longitudinal markers to
a model for multivariate survival data.
Our goal is to link the information of the L longitudinal markers and a model for
multivariate survival data (assuming that we have K survival times). To do so, we
proceed as follows. We begin by constructing the hazard for an individual with two
survival times and one longitudinal variable and then extend the case to K survival times
(again with only one longitudinal variable). Then, we focus on more than one longitudinal
variable. First, we study the case of two longitudinal variables (with only one survival
time) and then we construct the hazard for L longitudinal variables and one survival
time. Last step is taking into account both more than one survival time and more than
one longitudinal variable. To fix ideas, we start by studying the case where K = 2 and
L = 2 (two survival times and two longitudinal variables). This might help us set the
basis for reaching our goal, the model with K survival times and L longitudinal variables.
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As we have mentioned, this work was motivated by the TIBET clinical trial in which we
have to model two sequential times (T1 and T2 with T2 being observable only after T1 have
been observed) with longitudinal measurements. Our purpose is to take the longitudinal
measurements as a markers for the times to events. If there is an association between the
longitudinal and the survival processes, a joint modeling must be fitted to have proper
model estimations for both processes.
4.2 K survival times and one longitudinal variable
Multivariate survival data arises when we have a sequence of events E1, . . . , EK and its
failure times T1, . . . , TK collected from the same individual. These failure times can be
repetitions of the same kind of event or events of different type. We can distinguish (Lin
et al., 1999) between two different types of multivariate data:
1. Parallel data arises when for each individual we observe several failure times
(T1, . . . , TK) that do not satisfy any order restrictions and, thus, they can be
observed in parallel.
2. Longitudinal data (or sequential data) arises when for each individual we
observe a sequence of events over time (similar events that may occur several times
for each subject). The times can correspond to events of the same kind (recurrent
events) or they can be transitions between different states.
For our purposes, we will focus on sequential data, where we observe a sequence of times
T1i, . . . , TKi for the i-th individual. The times are observed in order (first T1i, then T2i
and so on) and they occur sequentially so, for each individual, Tj can only be observed if
T1, . . . Tj−1 have been previously observed. Because of this, subsequent times can depend
on their previous times. The TIBET clinical trial mentioned in Chapter 2 belongs to this
case because its transitions occur sequentially.
4.2.1 K = 2, L = 1: JMseq(2, 1)
We will study the situation of two survival times T ∗1 and T
∗
2 that may be right censored
by the censoring times C1 and C2 respectively. So, for each individual i = 1, . . . , n
and for each sequential time k = 1, 2, instead of observing T ∗ki, we observe (Tki, δki) where
Tki = min (T
∗
ki, Cki) and δki = I (T
∗
ki ≤ Cki), the indicator of whether T ∗ki is censored or not.
Again, instead of the true values of the biomarker mi(tij) we observe yi(tij) for i = 1, . . . , n
and j = 1, . . . , ni and where tij are the calendar times where the measurements are taken.
If T ∗1 and T
∗
2 are the two survival times, we can define the joint survival function as
S(t1, t2) = P (T
∗
1 > t1, T
∗
2 > t2) (4.1)
and the distribution function can be written as
F (t1, t2) = P (T
∗
1 ≤ t1, T ∗2 ≤ t2) . (4.2)
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From (4.1) we can formulate the marginal survival functions as
Sk(tk) = P (T
∗
K > tk)
and so we will have S1(t1) = S(t1, 0) and S2(t2) = S(0, t2).
We can proceed in a similar way with (4.2) and the marginal distribution functions will
be F1(t1) = F (t1, 0) and F2(t2) = F (0, t2).
Because the events occur to the same individual, the times will not be, in general,
independent. So the PH Cox model can not be used in this case because it assumes
conditional independence of the failure times given the covariates.
For our sequence of times, where T2 can not be observed until T1 has been observed, it is
neither possible to use simple pseudo-likelihood methods because they assume times are
independent given the covariates. In this case, models can be formulated as a sequence
of conditional distributions
For two sequential times T1 and T2, the sequence of conditional distributions can be
expressed as
F1 (t|wi; θ1) = P (T1i ≤ t|wi; θ1) , (4.3)
F2|t1,i (t|wi, t1,i; θ2, δ) = P (T2i ≤ t|wi, t1,i; θ2, δ) , (4.4)
where δ is the parameter association between T1 and T2, θ1 and θ2 are the vectors of the
parameters associated to the covariates of T1 and T2 models and t1,i is the observed time
(censored or not) for T1.
Considering two times to event, the data observed can be one of the three types:
1. T ∗1i is not observed. So, consequently, T
∗
2i neither. As we do not have any information
on T ∗2i, we defined δ2i = 0. In this situation we have T
∗
1i > C1i and δ1i = δ2i = 0.
Thus, the information that we gathered is (T1i, 0) with T1i = C1i for the first time
and (0, 0) for the second (because we have no information for T2i).
2. T ∗1i is observed and T
∗
2i is not observed. In this case, the information we have is
that T1i = T
∗
1i, T
∗
2i > C2i and, for the censoring indicator, δ1i = 1 and δ2i = 0.
The information for the first time will be (T1i, 1) with T1i = T
∗
1i and (T2i, 0) with
T2i = C2i for the second.
3. The situation in which both T ∗1i and T
∗
2i are observed. In this case, T1i = T
∗
1i,
T2i = T
∗
2i and δ1i = δ2i = 1 and thus, the information that we have is (T1i, 1) with
T1i = T
∗
1i for the first time and (T2i, 1) with T2i = T
∗
2i for the second.
In Figure 4.1 we can see data from three individuals together with the censoring indicators
in each case. First subject belongs to the first type above described. It has been censored
for the first survival time and, consequently, there is no information on its second time.
The second subject has been observed (black point) for the first survival time and censored
(white point) for the second. Last, subject number three has been observed for both first
and second survival times.
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Figure 4.1: Types of observed data. The black points represent observations of the event
of interest. The white ones stand for censored observations.
Based on these possibilities for observed data, the likelihood function may be written as
L (θ1, θ2, δ) =
n∏
i=1
[
f1 (t1,i|wi; θ1)δ1i S1 (t1,i|wi; θ1)(1−δ1i)
]
[
f2|t1,i (t2,i|wi, t1,i; θ2, δ)δ2i S2|t1,i (t2,i|wi, t1,i; θ2, δ)(1−δ2i)
]δ1i
. (4.5)
Thus, a model to analyze this kind of problems will be a model for T1 given baseline
covariates and longitudinal information and a model for T2 given baseline covariates,
longitudinal information and T1. First of all, we have to model the evolution of the
longitudinal variables along time. We can assume that these variables follow different
models such as linear in pieces, monotone (decreasing or increasing) with linear or
parabolic trend and combinations of them (a two piecewise model until the first time
to event and with a parabolic trend from then on, for instance). In this work, we assume
our longitudinal variable to be linear in two pieces and changing in T1. Thus, in the end,
we will have a value for the intercept and the slope for the first interval (from time zero
to T1) and a slope for the second interval (from T1 to T1 +T2). In the second interval, the
intercept will be the current value at T1 for each individual. This assumption of a linear
variable changing in T1 is due to the fact that because of the association between the
longitudinal and survival processes, it is highly likely that the longitudinal trend changes
because of the occurrence of the first event.
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Given a two piecewise linear mixed model, the longitudinal variable can be written as
yij = (β0 + bi0) + (β1 + bi1) [I2(tij)t1,i + (1− I2(tij)) tij]
+ I2(tij) (β2 + bi2) (tij − t1,i) + i (tij) , (4.6)
where t1,i is, as before, the observed time for T1 and I2 (tij) is the indicator of whether
the individual is at risk for the second event and can be written as I2(tij) = I(tij ≥ t1,i).
Thus, at a calendar time tij, if the individual has not experienced E1 yet, the longitudinal
variable is modeled through an intercept (β0) and an slope (β1) and their random effects,
whereas if t1,i has been already observed, (4.6) includes β2 to model the evolution of the
variable in the second interval of time as well as the random effect for the i-th subject
in this second interval. In this case, the amount of time the i-th individual has spent at
this second interval or, in other words, the time the individual has been at risk for T2, is
written as tij − t1,i.
From (4.6) we can see that we are assuming that both the intercept and the slope have
random effects in the two sections. Otherwise, the model can be easily adjusted to the
situation where only the intercept or the slope (or neither) have random effects. From
now on we will assume random effects in both the intercept and the slope. As we have
mentioned before, from (4.6) we can see that the model when the subject is at risk for T2
takes information from the previous longitudinal trajectory. In other words, the intercept
in this second interval is the current value for the subject at the moment in which the
previous event of interest has occurred.
As we have already said, in this work we are going to focus on a model with linear trend
changing in T1. For that case the hazard for an individual that has not experienced E1
yet can be written as
h1,i (t|Mi (t) ,wi) = h1,0(t) exp
{
γT1 wi + α1,1 [(β0 + bi0) + (β1 + bi1) t]
}
, (4.7)
with γ1 being the vector of coefficients of the baseline covariates wi that have effect in
T1. In (4.7) we introduced the parameter αk,l that denotes the association between the
the k-th sequential time and the l-th longitudinal variable (here, α1,1 that denotes the
association between the first survival time and the first (and only) longitudinal variable).
Thus, although it would have been easier to use α1 in (4.7), because there is only one
longitudinal variable, we have chosen to use the more complex notation α1,1 in order to
be consistent with next sections. Moreover, note that in (4.7) t stands for the time that
the individual is at risk for T1.
In a quite similar way and introducing δ2,1 to describe the relation between T1 and T2,
the hazard for and individual that has experimented E1 can be expressed as
h2,i (t|Mi (t1,i + t) ,wi, t1,i) = h2,0(t) exp
{
γT2 wi + δ2,1t1,i
+α2,1 [(β0 + bi0) + (β1 + bi1) t1,i + (β2 + bi2) t]} , (4.8)
where γ2 is the vector of the coefficients of the baseline covariates affecting on the second
interval and α2,1 is the association between survival and longitudinal processes in that
second interval. In (4.8) t represents the time the individual is at risk for T2.
Note that whereas in (4.7) we can only use the information from Mi(t), in (4.8) we
can use Mi(t1,i + t) because the subject has already experienced E1 and we can use the
information until t1,i + t to model the longitudinal variable in the second interval.
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4.2.2 L = 1: JMseq(K, 1)
In this section the notations and concepts for two sequential times will be extended
for the case of K survival times. Suppose we have K survival times T ∗k that may be
right censored with censure Ck for k = 1, . . . , K. As before, for each individual we
observe (Tki, δki) where Tki = min (T
∗
ki, Cki) and δki = I (T
∗
ki ≤ Cki) for k = 1, . . . , K and
i = 1, . . . , n.
If T ∗1 , . . . , T
∗
K are the K survival times associated to an individual, we can define their
joint survival function as
S(t1, . . . , tK) = P (T
∗
1 > t1, . . . , T
∗
K > tK) . (4.9)
The distribution function can be written as
F (t1, . . . , tK) = P (T
∗
1 ≤ t1, . . . , T ∗K ≤ tK) . (4.10)
Following the notation, the marginals for the survival function are
S1(t1) = S(t1, 0, . . . , 0) , . . . , Sk(tK) = S(0, . . . , 0, tK). (4.11)
As in the case of two sequential times, PH Cox model can not be used in this case because
it assumes conditional independence of the failures given the covariates and neither can
be applied simple pseudo-likelihood methods because they assume times are independent
given the covariates and this is not the case for our sequence of times, where Tj can not
be observed until T1, . . . , Tj−1 have been observed.
In order to arrive to a general formulation, we denote
∆k =
 δk,1...
δk,k−1
 (4.12)
as the vector of the relations for Tk and the previous times to event T1, . . . , Tk−1. The
components of this vector are expected to be decreasing in norm if Tk is more influenced
by Tk′ as k
′ is closer to k. Hence, as we move forward in time the first sequential times
tend to have less influence in the current time.
To ease the notation we also denote
Tki =
 t1,i...
tk−1,i
 (4.13)
as the observed times at which the i-th individual has experienced the previous k − 1
events of interest.
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With this notation, models for T1, T2, . . . , TK given covariates wi can be written as
Fk|Tki (t|wi,Tki; θk,∆k) = P (Tki ≤ t|wi,Tki; θk,∆k) , (4.14)
where, with Tki and ∆k we are using the information we have gathered in the previous
times.
As before, in order to construct a model capable of linking longitudinal variables to a
model for multivariate survival data first of all we have to model the evolution of the
longitudinal variables along time. We assume that we have a longitudinal variable that
has a linear trend changing in every Tk. We denote, for k ≥ 2, Ik(tij) = I(tij ≥
∑k−1
p=1 tp,i)
as the indicator of whether the i-th individual is at risk for Tk at time tij or, in other
words, if tij is bigger than the sum of the previous k − 1 times. For this indicator, we
define I1(·) ≡ 1 and IK+1(·) ≡ 0, meaning that tij is always at risk at the beginning and
never at risk after the last event. With this notation, the longitudinal variable for K
sequential survival times at a certain calendar time tij can be written as
yij = (β0 + bi0)
+
K∑
k=1
{
Ik(tij) (βk + bik)
[
Ik+1(tij)tk,i + (1− Ik+1(tij)) (tij −
k−1∑
p=1
tp,i)
]}
+ i (tij) ,
(4.15)
where the indicator Ik indicates if tij is at risk (at least) for Tk−1 (and, thus, we have to
take into account the effect of βk and bik) and the purpose of Ik+1 is to know if we are at
risk for Tk+1 or not. With this two indicators, we can always know in which interval tij
is and therefore, calculated the value of the longitudinal variable according to it.
In Figure 4.2 we can see the construction of the longitudinal variable when the individual
is at risk for a particular Tk. Apart from the intercept effect (fixed and linear, because
we are considering a specific subject i and thus we have to consider its deviation from the
marginal), as tij is bigger than tp,i, for p = 1, . . . , k−1, we have to include the effect of all
previous times. Therefore, for each time tp,i, meaning the time the individual has been
at risk for Tp, we add its contribution (βp + bip) tp,i to the longitudinal response. For the
k-th interval of time, we have to add up the effect of the time the individual has been at
risk for Tk, that is tij −
∑p−1
k=1 tk,i, through βk and bik.
Therefore, in particular, if we know that tij is at risk for a certain Tk the variable can be
written as follows
yij = (β0 + bi0) +
k−1∑
p=1
[(βp + bip)tp,i] + (βk + bik)
(
tij −
k−1∑
p=1
tp,i
)
+ i (tij) , (4.16)
where tij −
∑k−1
p=1 tp,i is the time the individual has been at risk for Tk or, in other words,
how much larger is tij from
∑k−1
p=1 tp,i.
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Figure 4.2: Construction of the longitudinal variable with sequential times. For each
interval of time we can see its contribution to the overall expression of the longitudinal
variable.
Using what we have developed for the case of two sequential times, the hazard for
an individual that has not yet arrived to T1 is (4.7) and for an individual that has
experimented E1 but not yet E2 is (4.8).
Analogously, for an individual that has experienced the first and second events and is t
units at risk for T3, the hazard can be written as
h3,i (t|Mi (t1,i + t2,i + t) ,wi, t1,i, t2,i) = h3,0(t) exp {γ3wi + δ3,1t1,i + δ3,2t2,i
+α3,1 [β0 + bi0 + (β1 + bi1) t1,i + (β2 + bi2) t2,i + (β3 + bi3) t]} . (4.17)
With the new variables Tki and ∆k that we have already introduced, we can extend the
expressions for the hazards that we have formulated before to the general case where
there are K sequential times. Thus the risk for a certain individual i at t units of risk for
the k-th time will be
hk,i
(
t
∣∣∣∣Mi
(
k−1∑
p=1
tp,i + t
)
,wi,Tk,i
)
= hk,0(t) exp
{
γkwi + ∆
T
kTki
+ αk,1
[
(β0 + bi0) +
k−1∑
p=1
(βp + bip) tp,i + (βk + bik) t
]}
. (4.18)
4.3 One survival time and L longitudinal variables
As we have mentioned, the majority of the work in the joint modeling literature has
focused on models with only one longitudinal outcome. However, in many longitudinal
studies, patients are measured repeatedly for several outcomes assumed to be associated
with the survival times and that are potentially predictive for the time-to-event. In this
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Section we will introduce the methodology for the joint modelization of L longitudinal
variables and one survival time, beginning with the case of two longitudinal variables and
extending it to the general case of L variables.
4.3.1 K = 1, L = 2: JMseq(1, 2)
As before, we will assume that our variables follow a linear piecewise model. Thus, the
two longitudinal variables can be written as
y1ij = (β10 + b1i0) + (β11 + b1i1) tij + 1i (tij) , (4.19)
y2ij = (β20 + b2i0) + (β21 + b2i1) tij + 2i (tij) , (4.20)
where using the subindex 1 or 2, we specified that the β’s and the random effects are
different for each variable.
And the hazard for a particular individual i will be
h1,i (t|Mi (t) ,wi) = h1,0(t) exp
{
γTwi + α1,1 [(β10 + b1i0) + (β11 + b1i1) t]
+α1,2 [(β20 + b2i0) + (β21 + b2i1) t]} , (4.21)
where for α1,1 and α1,2 we denote the association between the first survival time and the
first and second longitudinal variables, respectively.
We denote b1i = (b1i0, b1i1)
T and b2i = (b2i0, b2i1)
T the vector for the random effects of
the two variables and, in order to model the dependency between the two longitudinal
variables in the case of one survival time, we denote Γ1,2 as its symmetric covariance
matrix for the random effects and we can write
Γ1,2 =
(
D11 D12
D21 D22
)
, (4.22)
where
D21 = D
T
12.
To ease the notation for next sections, we define Dlm as the covariance matrix between
the l-th and the m-th longitudinal variables and σlm,pq as the covariance between the
p-th and the q-th random effect of the l-th and m-th longitudinal variables, respectively.
Thus, (4.22) can be written more explicitly as
Γ1,2 =

σ11,00 σ11,01 σ12,00 σ12,01
σ11,11 σ12,10 σ12,11
σ22,00 σ22,01
σ22,11
 . (4.23)
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Therefore, Γ1,2 is a symmetric matrix that has 4 rows and 4 columns and 10 different
components. This matrix models the relation between the random effects for the two
longitudinal variables. For example, if σ12,00 = cov(b1i0, b2i0) > 0, it means that the levels
of y1 and y2 at the intercept level from their mean population profile move towards the
same direction: if b1i0 goes up, so does b2i0. On the other hand, when cov(b1i0, b2i0) < 0,
if b1i0 goes up, b2i0 will go down and the other way round.
4.3.2 K = 1: JMseq(1, L)
For L longitudinal variables, and continuing with only one survival time, we can extend
the notation that we already had in (4.19) and (4.20) for the case of two variables to the
case of L variables and construct a set of L longitudinal variables as follows
y1ij = (β10 + b1i0) + (β11 + b1i1) tij + 1i (tij) , (4.24)
. . .
yLij = (βL0 + bLi0) + (βL1 + bLi1) tij + Li (tij) . (4.25)
If we denote α1,1, . . . , α1,L the associations between the survival time and the L
longitudinal variables and γ1 the effect of the vector of baseline covariates w for a certain
individual i, the hazard for this individual can be written as
h1,i (t|Mi (t) ,wi) = h1,0(t) exp
{
γT1 wi + α1,1 [(β10 + b1i0) + (β11 + b1i1) t]
+α1,2 [(β20 + b2i0) + (β21 + b2i1) t] + . . .
+α1,L [(βL0 + bLi0) + (βL1 + bLi1) t]}
= h1,0(t) exp
{
γT1 wi +
L∑
l=1
α1,l [(βl0 + bli0) + (βl1 + bli1) t]
}
. (4.26)
As before, and using the notation introduced in the previous subsection, we can construct
the block matrix Γ1,L that models the covariance between the random effects of all L
variables as
Γ1,L =

D11 D12 · · · D1L
D21 D22 · · · D2L
...
...
. . .
...
DL1 DL2 · · · DLL
 .
The blocks of this block matrix are
 L 2× 2 matrices Dll with l = 1, . . . , L and each one with 3 different components.

1
2
L (L− 1) different 2× 2 matrices Dlm (because Dml = DTlm) and each one with 4
different components.
To sum up, the matrix Γ1,L that gathers the information about the covariance between
the random effects associated with the L longitudinal variables is a 2L × 2L symmetric
matrix with 3L + 2L (L− 1) different components. In previous section, as we had 2
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longitudinal variables, L = 2 and we had a 4× 4 matrix with 3 · 2 + 2 · 2 · 1 = 10 different
components. More information on the parameters and the dimension of Γ1,L is available
in Table 4.1 at the end of this Chapter.
4.4 K sequential times and L longitudinal variables
In this next step we aim to joint the information given by K sequential survival times
with the information of L longitudinal variables to develop an expression for the hazard
for an individual when we have more than one survival time and information on more
than one longitudinal variable. First of all we study the case of 2 survival times and 2
longitudinal variables. Then, we extend it to the K sequential times and L longitudinal
variables’ case.
4.4.1 K = 2, L = 2: JMseq(2, 2)
If we have two different markers and each of them can be modeled as a longitudinal model
over T1 and T2, we have the case of two longitudinal variables and two sequential times to
event. The two longitudinal variables do not have to follow the same evolution thus, as
before, first of all we have to choose a proper model for each longitudinal variable. As we
choose to model them both with a piecewise model changing in T1, the two variables can
be written as in (4.6) but now we have to specify which variable (1 or 2) we are talking
about. Thus, in this case, the variables can be written as
y1ij = (β10 + b1i0) + (β11 + b1i1) [I2(tij)t1,i + (1− I2(tij)) tij]
+ I2(tij) (β12 + b1i2) (tij − t1,i) + i (tij) , (4.27)
y2ij = (β20 + b2i0) + (β21 + b2i1) [I2(tij)t1,i + (1− I2(tij)) tij]
+ I2(tij) (β22 + b2i2) (tij − t1,i) + i (tij) , (4.28)
where, as in (4.6), we are denoting t1,i as the time at which we have observed the first
event for individual i and I2(tij) = I(tij ≥ t1,i) as the indicator of whether tij is bigger
than t1,i or not. Thus, βk2 and bki2 for k = 1, 2 will have an effect on the hazard only if
tij is bigger than t1,i (that means, if at tij the individual is at risk for T2).
With the expression of the two variables we can construct the hazard for a particular
individual i that has not yet experienced E1 as follows
h1,i (t|Mi (t) ,wi) = h1,0(t) exp
{
γT1 wi + α1,1 [(β10 + b1i0) + (β11 + b1i1) t]
+α1,2 [(β20 + b2i0) + (β21 + b2i1) t]} . (4.29)
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And similarly, the hazard for an individual that has experienced E1 and therefore, is at
risk for T2, can be written as
h2,i (t|Mi (t1,i + t) ,wi, t1,i) = h2,0(t) exp
{
γT2 wi + δ2,1t1,i
+α2,1 [(β10 + b1i0) + (β11 + b1i1) t1,i + (β12 + b1i2) t]
+α2,2 [(β20 + b2i0) + (β21 + b2i1) t1,i + (β22 + b2i2) t]} .
(4.30)
Note that (4.29) and (4.30) are similar to (4.7) and (4.8) but now we have to include
the effect of the two longitudinal variables and, thus, we have two different association
parameters for each hazard, α1,1 and α1,2 for the hazard related with the first event and
α2,1 and α2,2 for the hazard related with the second.
In this scenario, we have more than one longitudinal variable and, therefore, we can
construct the covariance matrix between their respective random effects. As we are
considering two sequential times, each variable has three random effects (bki0, bki1 and
bki2). Therefore, with the notation that we have already introduced, the covariance matrix
for, for example, the random effects of the first variable can be written as
D11 =
 σ11,00 σ11,01 σ11,02σ11,10 σ11,11 σ11,12
σ11,20 σ11,21 σ11,22
 . (4.31)
Putting together the information obtained from the covariance matrix of each variable
and the covariance matrix between the two variables, the covariance matrix that describes
the relation between the random effects of both variables will be
Γ2,2 =
(
D11 D12
D21 D22
)
, (4.32)
where
D12 =
 cov(b1i0, b2i0) cov(b1i0, b2i1) cov(b1i0, b2i2)cov(b1i1, b2i0) cov(b1i1, b2i1) cov(b1i1, b2i2)
cov(b1i2, b2i0) cov(b1i2, b2i1) cov(b1i2, b2i2)
 =
 σ12,00 σ12,01 σ12,02σ12,10 σ12,11 σ12,12
σ12,20 σ12,21 σ12,22
. (4.33)
In conclusion,
Γ2,2 =

σ11,00 σ11,01 σ11,02 σ12,00 σ12,01 σ12,02
σ11,11 σ11,12 σ12,10 σ12,11 σ12,12
σ11,22 σ12,20 σ12,21 σ12,22
σ22,00 σ22,01 σ22,02
σ22,11 σ22,12
σ22,22.
 . (4.34)
Therefore, Γ2,2 is a symmetric matrix that has 6 rows and 6 columns and 21 different
components. For more information on the number of parameters or the dimension of the
block matrices, see Table 4.1 at the end of this Chapter.
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4.4.2 JMseq(K,L)
The final step is to joint the information of K sequential survival times and L longitudinal
variables. In a similar way as we did in (4.15), we can write the L longitudinal variables
as
y1ij = (β10 + b1i0)
+
K∑
k=1
{
Ik(tij) (β1k + b1ik)
[
Ik+1(tij)tk,i + (1− Ik+1(tij)) (tij −
k−1∑
p=1
tp,i)
]}
+ 1i (tij) ,
(4.35)
y2ij = (β20 + b2i0)
+
K∑
k=1
{
Ik(tij) (β2k + b2ik)
[
Ik+1(tij)tk,i + (1− Ik+1(tij)) (tij −
k−1∑
p=1
tp,i)
]}
+ 2i (tij) ,
(4.36)
. . .
yLij = (βL0 + bLi0)
+
K∑
k=1
{
Ik(tij) (βLk + bLik)
[
Ik+1(tij)tk,i + (1− Ik+1(tij)) (tij −
k−1∑
p=1
tp,i)
]}
+ 3i (tij) ,
(4.37)
where each of them is thought as having a linear trend that changes in each survival time.
This change at each Tk is modeled through the different K parameters β.
Thus, in this situation, the hazard for an individual must include the information given by
all the longitudinal variables, each one with its coefficient αk,l that denotes the association
between the k event time and the l-th longitudinal variable. Thus, for a certain individual
i, the hazard for a particular time t between 0 and the first event can be written as
h1,i (t|Mi (t) ,wi) = h1,0(t) exp
{
γT1 wi + α1,1 [(β10 + b1i0) + (β11 + b1i1) t]
+α1,2 [(β20 + b2i0) + (β21 + b2i1) t] + . . .
+α1,L [(βL0 + bi0) + (βL1 + bLi1) t]} , (4.38)
where only the first two fixed and random effects have an effect on the hazard because
as the individual has not experienced E1 yet, we can only use information on the first
interval and, thus, the longitudinal variable can be model with only the effects of the
intercept (βl0 and bli0) and the slope (βl1 and bli1), for l = 1, . . . , L, in that first interval
of time.
For the hazard for a time t between the first and the second event, we must include the
effect of the first observed time (t1,i) and the longitudinal variables expand to the second
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interval of time. Therefore, as in (4.30) but including the L longitudinal variables, the
hazard for a time t in the gap between the first and the second time-to-event will be
h2,i (t|Mi (t1,i + t) ,wi, t1,i) = h2,0(t) exp
{
γT2 wi + δ2,1t1,i
+α2,1 [(β10 + b1i0) + (β11 + b1i1) t1,i + (β12 + b1i2) t]
+α2,2 [(β20 + b2i0) + (β21 + b2i1) t1,i + (β22 + b2i2) t] + . . .
+α2,L [(βL0 + bLi0) + (βL1 + bLi1) t1,i + (βL2 + b2L2) t]} .
(4.39)
In general, for a general k, k = 1, . . . , K, using variables Tki and ∆k to include the effect
of previous times and using the association variables αk,1, . . . , αk,L to use the information
from the L longitudinal variables, we can write the hazard for a particular individual i
that is at risk for the k-th event as
hk,i
(
t
∣∣∣∣Mi
(
k−1∑
p=1
tp,i + t
)
,wi,Tk,i
)
= hk,0(t) exp
{
γTk wi + ∆
T
kTki
+ αk,1
[
(β10 + b1i0) +
k−1∑
p=1
(β1p + b1ip) tp,i + (β1k + b1ik) t
]
+ αk,2
[
(β20 + b2i0) +
k−1∑
p=1
(β2p + b2ip) tp,i + (β2k + b2ik) t
]
+ · · ·
+ αk,L
[
(βL0 + bLi0) +
k−1∑
p=1
(βLp + bLip) tp,i + (βLk + bLik) t
]}
= hk,0(t) exp
{
γTk wi + ∆
T
kTki
+
L∑
l=1
αk,l
[
(βl0 + bli0) +
k−1∑
p=1
(βlp + blip) tp,i + (βlk + blik) t
]}
. (4.40)
The design of the covariance matrix for the random effects of all variables is a bit more
complicated in this case because we have to acknowledge not only the information about
the L longitudinal variables but also the information about the K sequential survival
times. The matrix design in blocks will be
ΓK,L =

D11 D12 · · · D1L
D21 D22 · · · D2L
...
...
. . .
...
DL1 DL2 · · · DLL
 .
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And the blocks of this block matrix are
 L (K + 1)×(K + 1) matrices Dll with l = 1, . . . , L, each one with 12 (K + 1) (K + 2)
different components.

1
2
L (L− 1) different (K + 1) × (K + 1) matrices Dlm (because Dml = DTlm), each
one with (K + 1) (K + 1) different components.
The construction of this matrices is similar to the one we did in the case of two sequential
survival times and two longitudinal variables. More information on parameters and
dimensions is available in Table 4.1 at the end of this Chapter.
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Chapter 5
Towards JMseq(K,L) algorithm:
packages JM and JMbayes
5.1 Introduction
The R packages JM (Rizopoulos, 2010) and JMbayes (Rizopoulos, 2014a) for the frequentist
and Bayesian approaches of joint modeling have facilitated a lot the application of
joint model methodology to real case examples. In this Chapter we aim to study the
differences and similarities between both packages in terms of how they work and what
we can do with each of them. First we will present the internal structure of their main
estimation functions and then detect which parts need to be modified in order to allow
the incorporation of more than one time to event and the information on more than one
longitudinal variable.
In order to ease reading, in this Chapter we have avoided the technical details of the
implementation of the packages, such as the utilization and manipulation of different
types of objects, the construction of mechanical procedures to deal with integrals and
other complex operations or the implementation of several internal functions that are
used in particular moments. Therefore, although we have taken an in-depth look into the
implementation, we present the information here without explicitly referring to the code.
In this Chapter we examine the two main functions in JM and JMbayes: jointModel() and
jointModelBayes(). Both functions fit shared parameter models for the joint modeling
of longitudinal responses and time-to-event data although jointModel() does it under a
maximum likelihood approach and jointModelBayes() under a Bayesian perspective.
With all the knowledge acquired from studying the structure of these estimation functions,
we will be able to design a procedure towards the estimation of JMseq(K,L), the joint
model function for K sequential survival times and L longitudinal variables.
39
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5.2 Package JM
Introduction
The R package JM has been developed to fit a variety of joint models for normal
longitudinal responses and time-to-event data under maximum likelihood. Although
the main function in JM package, jointModel(), can account for several issues such as
competing risks, different types of censoring or different approximations for the baseline
hazard function, we will focus on the structure of the function when fitting a model using
splines to approximate the baseline hazard function and assuming that the risk for an
event at time t is associated with the subject-specific mean of the longitudinal outcome
at the same time point. We study models with these characteristics in order to easily
compare functions jointModel() and jointModelBayes().
5.2.1 Base structure
The two main arguments needed to call the model-fitting function are a linear mixed
effects object fit as returned by function lme() of package nlme (Pinheiro et al., 2012)
and a survival object fit as returned by function coxph() of package survival (Therneau,
2013).
The jointModel() function follows the next algorithm:
1. With the information from the lme and the survival objects, extraction of
information and construction of the longitudinal variable y = Xβ + Zb.
Ť
2. Construction of a list of information about elements that deal with the control of the
function. This list includes information on the iterations for the EM and the Newton
algorithm, the tolerance to declare EM convergence, the knots and the order of the
spline to approximate the baseline risk function and the number of Gauss-Hermite
quadrature points used to approximate the integral with respect to random effects
(3.9) and the Gauss-Kronrod points to approximate the integral in the definition of
the survival function (3.10).
Ť
3. With the number of points specified in the control argument, computation of the
Gauss-Kronrod weights and knots.
Ť
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4. Construction of the knots in order to evaluate the design matrix for the B-splines
to approximate the log baseline hazard risk function.
Ť
5. With the information on the knots, the order of the spline and the times where we
want to evaluate it, construction of the design matrix for the B-splines.
Ť
6. From the lme model, extraction of the covariance matrix for the random effects.
Ť
7. Through initial.surv function (that it will be explained in detail in the next
section), construction of the initial values for the survival parameters.
Ť
8. Assemblage of the initial values for parameters from both the survival and the
longitudinal models.
Ť
9. Through function spline.PHGHfit (in this case, because we are approximating the
log baseline hazard with splines) and with all the information about the parameters,
the initial values and the control arguments that we have obtained in the previous
steps of the algorithm, estimation of the parameters of the joint model and their
confidence intervals.
Ť
10. Construction of the object that the function will return, that will be an object of
class jointModel.
5.2.2 Most important procedures
In this section we will discuss in more detail some parts of the jointModel() code. We
begin by analyzing its two main internal functions.
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initial.surv()
Using information about the different times to event from each individual, the β
parameters from the estimation of the lme object and the design matrix from the B-
splines, this function returns initial estimations (that will be used in the function that
computes the final estimations) for parameters γh0 in (3.4):
log h0(t) = γh0,0 +
Q∑
q=1
γh0,qBq(t, ν)
and parameters α and γ in (3.5):
hi(t|Mi(t),wi) = h0(t) exp{γTwi + αmi(t)}.
The function is structured as follows:
1. With the information about the covariates and the survival events, construction of
a data.frame with all the information needed to fit a Cox model.
2. Through the function paste(), construction of the formula of the Cox model to be
fitted.
3. Fitting of a Cox proportional hazards model with the covariates in the previous
data.frame.
4. From the Cox model adjusted, collection of the coefficients for α and γ.
5. Fit a parametric survival regression model with an assumed Weibull distribution in
order to obtain preliminary estimations for the coefficients γh0 .
6. Assembling the estimation of the parameters in the object to be returned.
Estimation Function
Maximum likelihood estimates are obtained by maximizing the log-likelihood function
log (L (θ)) = ∑i log p (Ti, δi,yi,θ). The integral in (3.9) is approximated using the Gauss-
Hermite rule and the integral in (3.10) is approximated using the Gauss-Kronrod rule
(Press et al., 2007). The maximization of the log-likelihood starts with a fixed number of
EM iterations. EM algorithm (Dempster et al., 1977) is an iterative method for finding
maximum likelihood estimates of parameters. It alternates between an expectation step
(E), that creates a function for the expectation of the log-likelihood evaluated using the
current estimate for the parameters, and a maximization step (M), that maximizes the
log-likelihood found in the previous step and computes estimates for parameters. These
estimates are used to determine the distribution of variables in the next E step. If, after all
the EM iterations, convergence is not achieved, the algorithm switches to quasi-Newton
iterations until convergence. For the EM iterations, convergence is declared whenever
one of the following criteria is satisfied:
max
{|θit − θ(it−1)/ (|θ(it−1)|+ tol1)} < tol2,
L
(
θit
)− L (θit−1) < tol3 {|L (θ(it−1)) |+ tol3} ,
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where θit denotes the parameter values at the it-th iteration, L (·) is the log-likelihood
function and tol1, tol2 and tol3 are specified via the control argument (default values are
10−3, 10−4 and 10−8, respectively). In the control argument the user can also specify
the optimization routine for the quasi-Newton iterations and the number of quadrature
knots for the Gauss-Hermite and the Gauss-Kronrod rules.
5.3 Package JMbayes
Introduction
The R package JMbayes fits joint models under a Bayesian approach. JMbayes can
fit a wide range of joint models, including joint models for continuous and categorical
longitudinal responses. Moreover, it provides several options for modeling the association
structure between the two outcomes. In many regards, the design of package JMbayes
is similar to the one of package JM. Thus, although function jointModelBayes() allows
a lot of choices, for example, the type of association between both processes or the
estimation of the baseline risk function, to study its structure we are going to focus, as in
function jointModel(), on the case in which the baseline risk function is approximated
via regression splines and it is assumed a relative risk model as in (3.2), i.e. the risk for an
event at time t is associated with the subject-specific mean of the longitudinal outcome
at the same time point.
5.3.1 Base structure
In a similar way as in jointModel() function, the main arguments needed to call
the jointModelBayes() function are a linear mixed effects object as the one that fits
function lme() of package nlme and a survival object fit by function coxph() or function
survreg() of package survival.
With these two main arguments, the function jointModelBayes() is structured in the
following steps:
1. With the information from the lme and the survival objects, extraction of
information and construction of the longitudinal variable y = Xβ + Zb.
Ť
2. Construction of a function to define the density of the longitudinal outcome.
Ť
3. Construction of a function to define the density of the random effects.
Ť
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4. Extraction of the covariance matrix from the random effects model.
Ť
5. Construction of the control parameter, which includes information about the
iterations in the Markov chain Monte Carlo method (such as the number of total
iterations or how many iterations are used for adaptation or are discarded as burn-in)
and about the knots and the order of the spline to approximate the log baseline risk
function.
Ť
6. Calculate the Gauss-Kronrod weights and knots used to approximate the survival
function in (3.14).
Ť
7. Construct the numeric vector of knots for the spline approximation of the log
baseline risk function and evaluate the design matrix for the B-splines. The location
of the knots can be based on percentiles of the observed event times Ti or on percentiles
of the true event times {Ti: T ∗i ≤ Ci}.
Ť
8. Through initSurvival() function (that we will explain in detail in the
next section), obtention of the initial values for the survival parameters and their
covariances.
Ť
9. If the user has not specified user-defined priors, construction of the prior mean
vectors and prior precision matrices for α, γ, γh0 and for the fixed and random effects.
In particular, for the vector of fixed effects of the longitudinal submodel β, for the
regression parameters of the survival model γ, for the vector of spline coefficients for
the baseline hazard γh0 and for the association parameter α, independent univariate
non-informative normal priors are used. For the covariance matrix of the random
effects an inverse Wishart prior is assumed.
Ť
10. Construction of an object that gathers the information about all the parameters’
covariances.
Ť
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11. Through function MCMCfit() and with all the information obtained and
constructed until this point, estimation of the parameters of the model.
Ť
12. Construction of the object that the function will return, that will be an object of
class JMbayes.
5.3.2 Most important procedures
In this section we will discuss in more detail some parts of the jointModelBayes()
function. We begin with its two main internal functions.
initSurvival()
This function returns the initial estimation of parameters α and γ in (3.5) and γh0 in
(3.4) and their covariances. The function is structured as follows:
1. With the information received about the covariates and the survival events,
construction of a data.frame with all the information needed to fit a Cox model.
2. Fitting of a time-dependent Cox model with the covariates in the previous
data.frame.
3. From the coefficients from the Cox model, compilation of the coefficients for α and
γ and the first estimation for its covariances.
4. Construction of γh0 and its covariance matrix via searching the optimal values in
the optimization of a function for the B-splines.
5. With matrices multiplications and functions to calculate the integrals in (3.13) and
(3.14), definition of a function that computes (3.13). Taken the estimates for γ,
α and γh0 as initial parameters, optimization of the function in order to obtain
the values that minimize it and use them as the best estimates for the survival
parameters and its covariances.
6. Gathering the estimate parameters and their covariances in the object to be
returned.
MCMCfit()
This internal function is the implementation of the MCMC algorithm that samples from
the posterior conditional distributions of the parameters and the random effects. For the
majority of the posterior conditional random walk Metropolis is used with exceptions such
as that when the random effects are assumed normally distributed (this can be controlled
with argument df.RE), the posterior conditional distribution for the random effects
precision matrix D−1 is a Wishart distribution. The implementation uses the information
of the separately fitted mixed effects model and Cox models to obtain the covariances
matrices of the distributions for the random walk Metropolis algorithm (which is a Markov
chain Monte Carlo (MCMC) method for obtaining a sequence of random samples from
a probability distribution). On the one hand, for β and bi, the covariance matrices are
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taken from the mixed model. On the other hand, for the regression coefficients in the
linear predictor of the survival submodel and the B-spline coefficients γh0 , a two-stage
approach is applied.
First of all, during and adaptive phase (default value is 3000), these proposal distributions
are tuned and every a pre-specified number of iterations (default is 100) the acceptance
rate of the algorithms are checked. Then there is a burn-in period (default is 3000)
and after that, the algorithm continues to run for extra iterations (default is 200000).
The chains of the parameters are thinned according to an argument specified by the user
(default is to keep 2000 iterations for each parameter). Thus, after each calculation, if the
iteration has to be kept, the results are stored in its correspondent variables. Although
at the end of the process the function returns the means of these variables as well as the
variables values, when a summary() is executed, only the means are reported.
5.4 Similarities and differences between JM and
JMbayes
After studying in detail the structure of the estimation functions in JM and JMbayes, in
this section we will comment differences and similarities between them. First of all, we
will go through the differences in two arguments that we have already brought out (the
choice of the approximation of the baseline risk function and the parameterization of the
lineal predictor for the survival model). Then, comparing the structures of jointModel()
and jointModelBayes(), we will note their main differences.
5.4.1 Baseline risk function
One of the differences between the two packages is the options available for the baseline
risk function h0(t). As we have noted before, although in a Cox Model the baseline risk
function can be left unspecified, it is not the case for the joint models so, in order to
avoid underestimation of the standard error of the parameter estimates it is necessary to
choose a proper h0(t).
The choice of h0 is specified through the argument baseHaz in JMbayes and method in
JM. In JMbayes we have only two choices, regression splines or penalized splines. For
regression splines, the logarithm of the baseline hazard function is expressed as
log h0(t) = γh0,0 +
Q∑
q=1
γh0,qBq(t, ν)
where Bq(t,ν) denotes the q-th basis function of a B-spline with knots ν = (ν1, . . . , νQ)
and γh0 is the vector of spline coefficients. Note that as the number of knots increases,
the specification of the baseline hazard becomes more flexible. The penalized version can
be fitted by specifying for γh0 the improper prior (Rizopoulos, 2014b)
p (γh0|τh) ∝ τ ρ(K)/2h exp
(
−τh
2
γTh0Kγh0
)
(5.1)
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where τh is the smoothing parameter, K = ∆
T
r ∆r where ∆r denotes the differences matrix
and ρ(K) is the rank of K.
Whereas the argument baseHaz in jointModelBayes() specifies only the type of survival
model to be fitted, the argument method in the function jointModel() gives information
not only about the survival model but also about the numerical integration method to
approximate the integral in (3.9). Available options are:
 "weibull-AFT-GH" that assumes the Weibull model under the accelerated failure
time or the relative risk formulation.
 "piecewise-PH-GH" which assumes the relative risk model with a piecewise risk
function as the one we defined in Chapter 3:
h0(t) =
Q∑
q=1
ξqI (νq−1 < t < νq) ,
where 0 = ν0 < ν1 < · · · < νQ is a split of the time scale (with νQ being larger than
the largest observed time) and ξq denotes the value of the hazard in the interval
(νq−1, νq) .
 "Cox-PH-GH" that uses a relative risk model with an unspecified baseline risk
function. This option is the one proposed by Wulfsohn and Tsiatis (1997).
 "spline-PH-GH" that assumes a relative risk model with a spline-approximated
baseline function. The baseline risk function log h0(t) is expanded as in (3.4).
The string "GH" indicates the type of Gauss-Hermite rule to be used to approximate
(3.9). If the chosen option for the method contains the string "GH", the standard Gauss-
Hermite quadrature is used, whereas if the string is "aGH", the type of rule used is the
pseudo adaptive Gauss-Hermite (Rizopoulos, 2013). The only option that does not use
the Gauss-Hermite rule is "ch-Laplace". This option assumes a similar survival model
as the one in "spline-PH-GH" but the approximation of the integral in (3.9) is done by
using a fully exponential Laplace transformation. This is useful in settings where the
subject-specific longitudinal profiles are nonlinear and thus, modeling them using Gauss-
Hermite can be time consuming due to the high dimension of the random effects. The
Laplace method gives a quite reasonable approximation in less computing time.
5.4.2 Linear predictor for the survival submodel
Both JM and JMbayes allow the choice of the linear predictor for the survival model
(through argument param in JMbayes and parameterization in JM). Thus, the lineal
predictor for the survival model is written as
γTwi + f (mi(t),m
′
i(t), bi;α, αs) . (5.2)
In particular, through the specification of function f (mi(t),m
′
i(t), bi;α, αs), the options
available for the association are:
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 f (mi(t),m
′
i(t), bi;α, αs) = αf1 (mi (max (t− k) , 0)) for "param = td-value" and
"parameterization = value".
 f (mi(t),m
′
i(t), bi;α, αs) = αsf2 (m
′
i (max (t− k) , 0)) for "param = td-extra" and
"parameterization = slope".
 f (mi(t),m
′
i(t), bi;α, αs) = αf1 (mi (max (t− k) , 0)) +αsf2 (m′i (max (t− k) , 0)) for
"param = td-both" and "parameterization = both".
 f (mi(t),m
′
i(t), bi;α, αs) = α
T bi for "param = shared-RE" (option not available in
JM).
 f (mi(t),m
′
i(t), bi;α, αs) = α
T (β + bi) for "param = shared-betasRE" (option not
available in JM),
where in all these cases k is specified by the lag argument, f1 (·) and f2 (·) denote possible
transformation functions, bi denotes the vector of random effects for the i-th subject and
β the fixed effects.
5.4.3 Structure differences
As we have already said, the design of package JMbayes is similar to the one of package
JM. Therefore, although they fit joint models under different perspective, there are a
lot of common points between them. In this section, we will make a compendium
of the differences in the algorithms in their estimating functions, which we have
already explained in the previous section. Thus, the main differences between functions
jointModel() and jointModelBayes() are:
 The arguments in the control element. The two packages have different ways
to estimate parameters; thus, the elements they need to control the estimations’
procedures are different. On the one hand, for the JM case, the iterations for the EM
and quasi-Newton algorithms or the tolerance to declare convergence are needed.
On the other hand, JMBayes has to keep track of the iterations in the MCMC
method. There are also common parameters for both functions, such as the knots
and the order of the spline use to approximate the log baseline risk function.
 When computing the initial estimates for the survival parameters, whereas for α
and γ the method is the same in both functions, to give initial estimates for γh0 ,
the functions proceed in different ways: jointModel() fits a survival regression
model with a Weibull distribution and jointModelBayes() constructs functions to
compute the integrals in the likelihood estimation and optimize them in order to
obtain the γh0 estimates.
 The main difference between both packages is the procedure used to estimate the
parameters. Whereas the frequentist approach uses an EM algorithm, the Bayesian
one takes profit of the Monte Carlo Markov Chain method. In this step is where
the parameters in the control argument are used. Moreover, for the Bayesian
estimation it is also necessary to construct the prior mean vectors and the prior
precision matrices for all parameters in the model.
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5.5 Extension towards JMseq(K,L)
To extend the procedures analyzed in this Chapter to the case of K sequential survival
times and L longitudinal variables, we are going to focus on the Bayesian perspective
because, as long as we know, this option is more flexible than the frequentist one in terms
of introducing changes.
One of the most important issues is to detail the input objects for the estimation function,
because these objects are the ones that provide the majority of the information needed
to fit the joint model. Whereas in the jointModelBayes() function the inputs were an
lme object and a Cox model, in the case we are studying arises the necessity to include
much more information through these initial objects:
 To include the information about the L longitudinal variables, we will need to fit L
different lme models, one for each longitudinal variable. Because these lme objects
will assume that variables are independent, we have to implement a procedure to
account for the correlation between them. In other words, we have to manually
construct the matrix that accounts for the correlation between variables (we have
explicitly written this ΓK,L matrix in Chapter 4). Thus, the joint model function we
are implementing should have an argument to specify the structure of the covariance
matrix for each couple of variables because, in general, we can not assume that
every pair of longitudinal variables have the same correlation. If the user does not
specify this structures, as a default value we could assume that the matrices are
unstructured, and estimate all the parameters in them (see Table 4.1 for more details
on the number of parameters for ΓK,L) but this will lead to a very computationally
demanding procedure. On the other hand, if the user does not specify which
relation exists between the variables, we can assume that their random effects are
independent and, thus, construct the block matrices outside the diagonal of ΓK,L
as matrices filled with zeros. With the specification of the relation between all the
pairs of variables, we will have the complete information about the longitudinal
part of the model that we need in order to estimate the joint model.
 For the survival part, we need to fit K Cox models, one for each sequential
time. The Cox models will model gap times tk,i, k = 1, . . . , K, with information
about baseline covariates (covariates that can be different for different times) and
information about the previous times, because their length can have an effect on
the estimation of the following times. Thus, for example, the Cox model for t3,i
will take information from the baseline covariates that have an effect on the third
interval of time as well as information from t1,i and t2,i. This information about
t1,i and t2,i will be acknowledged with parameters δ3,1 and δ3,2. These δ parameters
can explain both correlation between one time and the previous observed times and
also the potential mechanism of censoring that can affect the relation between one
time and the preceding ones.
Once we have determined the objects that will be used as main arguments in the function
to estimate JMseq(K,L), we are going to detail its algorithm. The structure will be
similar to the one in the package JMbayes but will include some modifications to deal
with the incorporation of sequential times and several longitudinal variables.
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The steps of the algorithm will be:
1. In the same way as we did in jointModelBayes(), with the information from the
L lme and K survival objects, extraction of information and construction of the L
longitudinal variables y = Xβ + Zb.
Ť
2. Construction of functions to determine the density of the longitudinal outcomes.
In this case, we will have L different functions because we can not assume that all L
variables follow the same distribution.
Ť
3. In a similar way, construction of the function to compute the density of the random
effects for all longitudinal variables. Again, we will have L different functions, each
one adjusting the density of the random effects of one of the variables.
Ť
4. Extraction of the L covariance matrices from the lme objects. These matrices are
the matrices in the diagonal of ΓK,L. With the information the user has provided
about the covariance between all pairs of longitudinal variables, we can construct the
matrices outside the diagonal. Therefore, at this point we have enough information
to explicitly construct ΓK,L in order to estimate its parameters.
Ť
5. In order to have some control over the function, we have to construct an object
to gather information about, for example, the iterations in the Markow chain Monte
Carlo method or the knots and the order of the spline to approximate the baseline
hazard function.
Ť
6. As we did in the function to estimate JMseq(1, 1), computation of Gauss-Kronrod
weights and knots used to approximate the survival function.
Ť
7. Construction of the numeric vector of knots for the spline approximation of the
logarithm of the baseline risk function. In this case, since knots depend on times,
we will have a pack of knots for each sequential time. Using these different knots to
evaluate the design matrix for the B-splines, we will get K different design matrices.
Ť
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8. In this next step, similarly as initSurvival() in jointModelBayes() and
init.surv() in jointModel(), we have to construct an internal function to obtain
initial estimations for the parameters of the survival part. We have to proceed in
a similar way as we did in previous steps, extending the procedure for one survival
time to K.
First of all, we have to construct K different data.frames with all the information
needed to fit a Cox Model for each sequential times. Because each data.frame
contains different information, the Cox Model fitted for each sequential time will
provide different estimations. These estimations will be the estimates of parameters
γk, αk,l and δk,1, . . . , δk,k−1 with k = 1, . . . , K and l = 1, . . . , L from formulas in
Section (4.4.2) and their covariances.
To obtain initial estimations for the γh0 parameters in the approximation of the
logarithm of the baseline risk function, we will use the function define in initSur-
vival() and use its optimal values as our γh0 estimations. We will have to run the
function K times because the estimations will be different for each h0.
Finally, analogously as we did in JMseq(1, 1), with the initial estimations of
the parameters for the Cox model, and adapting the function implemented in
initSurvival() to include information from the L longitudinal variables, we will
find the optimal values of the function and use them as best estimates for the survival
parameters and its covariances.
Ť
9. Construction of the prior means and prior precision matrices for αk,l, γk, γh0 and for
the fixed and random effects of all variables. For the parameters that JMseq(1, 1) and
JMseq(K,L) share, we will assume the same distributions as in jointModelBayes().
For the new parameters, δk,1, . . . , δk,k−1 for k = 1, . . . , K we assume also independent
univariate non-informative normal priors whereas for the covariance matrices between
the random effects of different longitudinal variables (matrices outside the diagonal
of ΓK,L) we would assume distributions that capture the dependency between the L
different lme objects.
Ť
10. Gathering of all parameters’ covariances in an object that will be used when
calling function MCMCfit().
Ť
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11. MCMCfit() function will estimate the parameters of the model, running as much
iterations as we have defined in control argument and using the priors defined to get
the initial estimations for the parameters.
Ť
12. Construction of the object that the function will return, that will be an object of
class JMseq.
Chapter 6
Discussion and future research
6.1 Discussion and conclusions
In clinical studies, it is increasingly common to measure the association between a
longitudinal variable and the risk for an event. Because these longitudinal variables
are usually time-dependent, separate analysis of survival and longitudinal data can lead
to biased results. Therefore, a jointly modelization of both approaches is needed in order
to correctly acknowledge the link between both survival and longitudinal processes.
Joint modeling can be approached from frequentist and Bayesian perspectives and in
this work we have highlighted that, although they have several points in common, they
have major differences in terms of estimation. From the joint modeling perspective,
most of the work has focused on models with one longitudinal outcome and one survival
time. Nevertheless, an issue that often arises in studies on health-related disciplines is
that patients generate a series of outcomes that can be used as longitudinal variables.
Moreover, it is also of interest to study multiple survival times for each patient, such as
sequential survival times.
The main goal of this work has been to understand joint modeling from frequentist
and Bayesian points of view and to develop a methodology able to incorporate in a
joint model sequential survival times and information from more than one longitudinal
covariates. This work was motivated by the TIBET clinical trial, that contemplated
the incorporation of interruption periods in the administration of an intensive therapy
for HIV infected patients, which generated a sequence of survival times for each subject
under study. Because we have information on times without treatment and times with
treatment along with the measurements of CD4 cell counts and viral load, this leads us
to a joint modeling with K sequential survival times and L longitudinal variables, what
we have denoted JMseq (K,L).
Firstly, we have presented the joint modeling approach for one survival time and one
longitudinal covariate and extended it for what we have called JMseq (K,L). After that,
we have illustrated how R packages JM and JMbayes work by showing an application to
the TIBET study, concluding that both approaches lead to similar results. Then, working
towards the implementation of a procedure able to compute estimates for JMseq (K,L)
and taking advantage of the already developed R packages JM and JMbayes, we have
analyzed the estimation functions in both packages and pointed out what parts of the
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implementation should be modified and how to modify them to incorporate the effect of
K sequential survival times and L longitudinal variables.
After studying and comparing the frequentist and Bayesian approaches, we have reach the
conclusion that, in terms of extending the already implemented procedures, the Bayesian
one allows more flexibility to include more survival times and more longitudinal variables.
Thus, in a future implementation of a procedure for JMseq (K,L) the focus will be on
implementing a procedure similar to jointModelBayes().
To conclude, with the development of the methodology for JMseq (K,L) the profits of a
sequential approach when having sequential survival times and longitudinal variables have
been explored. Moreover, we have experimented the meticulous work that is implementing
a procedure in terms of programming as well as the computational issues that can arise.
6.2 Future research
The research that has been carried out in this master’s degree thesis opens some areas
of interest in the joint modeling area that deserve further attention. They can be
summarized as follows:
 The work we have developed in this master’s degree thesis can be considered a first
step towards the implementation of a function that, in a similar way to the function
jointModelBayes(), would fit joint models for sequential survival times and several
longitudinal variables. Thus, using what is already implemented, the next step
would be the implementation in R of a joint model function for K sequential survival
times and L longitudinal variables.
 Although we have assumed that the risk for an event at time t is associated with
the subject-specific mean of the longitudinal outcome at the same time point, it
would be reasonable to consider that also the slope of the longitudinal trajectory at
this time has an effect on the hazard function. Therefore, we could explore different
associations between the risk for an event and the longitudinal outcome.
 Another issue is that, once the joint models have been validated, we can work with
the powerful tool already available in JM and JMbayes packages that derives results
in terms of survival predictions. Thus, with the set of longitudinal measurements
and the vector of baseline covariates for a new subject, the goal would be to predict
conditional probability of surviving time for that particular subject. This approach
is towards personalized medicine, an issue that has capture professionals attention
in recent years.
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Appendix A
R code
> ##############
> ##LIBRARIES##
> ##############
> library(survival)
> library(nlme)
> library(JM)
> library(JMbayes)
> library(xtable)
> #############################################
> ##FUNCTIONS TO COMPUTE CONFIDENCE INTERVALS##
> #############################################
> confint2log <- function(jm, alpha=0.05){
+ ## sigma
+ se.logsigma <- sqrt(vcov(jm)["Y.sigma", "Y.sigma"])
+ sigmahat <- jm$coefficients$sigma
+ se.sigma <- se.logsigma*sigmahat
+ ic.sigma <- c(sigmahat-qnorm(1-alpha/2)*se.sigma,
+ sigmahat+qnorm(1-alpha/2)*se.sigma)
+ return(ic.sigma)
+ }
> confint2quadrat <- function(sigmabhat, se.sigmab2, alpha=0.05){
+ # se(sigmab)
+ se.sigmab <- se.sigmab2/(2*sigmabhat)
+ ic.sigmab <- c(sigmabhat-qnorm(1-alpha/2)*se.sigmab,
+ sigmabhat+qnorm(1-alpha/2)*se.sigmab)
+ return(ic.sigmab)
+ }
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> ###########################
> ## MODELS FOR T1 AND CD4 ##
> ###########################
> ##read data
> dades <- read.table("dades_T1CD4.txt", sep="\t",head=T)
> dades.id <- dades[!duplicated(dades$ID),]
> ##survival model
> coxfit <- coxph(Surv(T1,d)~log10(VLpret),data=dades.id,x=TRUE)
> ##lme model
> lmefit <- lme(sqrt(CD4)~obstime,random=~obstime|ID, data=dades)
> ##joint model
> jm <- jointModel(lmefit,coxfit,timeVar="obstime",
+ method="spline-PH-aGH")
> summary(jm)
> ##joint model bayes
> jmb <- jointModelBayes(lmefit,coxfit,timeVar="obstime",
+ baseHaz="regression-splines")
> summary(jmb)
> ##confidence intervals
> confint(jm)
> confint(jmb)
> xtable(jm)
> xtable(jmb)
> confint2log(jm)
> confint2log(jmb)
Appendix A. R code 60
> ##################################
> ## MODELS FOR T1 AND VIRAL LOAD ##
> ##################################
> ##read data
> dades <- read.table("dades_T1CV.txt", sep="\t",head=T)
> dades.id <- dades[!duplicated(dades$ID),]
> ##survival model
> coxfit <- coxph(Surv(T1,d)~sqrt(CD4N),data=dades.id,x=TRUE)
> ##lme model
> lmefit <- lme(log10(CV)~obstime,random=~1|ID, data=dades)
> ##joint model
> jm <- jointModel(lmefit,coxfit,timeVar="obstime",
+ method="spline-PH-aGH")
> summary(jm)
> ##joint model bayes
> jmb <- jointModelBayes(lmefit,coxfit,timeVar="obstime",
+ baseHaz = "regression-splines")
> summary(jmb)
> ##confidence intervals
> confint(jm)
> confint(jmb)
> xtable(jm)
> xtable(jmb)
> confint2log(jm)
> confint2log(jmb)
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> ##############################
> ## MODELS FOR T1+T2 AND CD4 ##
> ##############################
> ##read data
> dades <- read.table("dades_T1T2CD4.txt", sep="\t",head=T)
> dades.id <- dades[!duplicated(dades$ID),]
> ##survival model
> coxfit <- coxph(Surv(T1T2,d)~log10(VLpret),data=dades.id,x=TRUE)
> ##lme model
> lmefit <- lme(sqrt(CD4)~obstime,random=~obstime|ID, data=dades)
> ##joint model
> jm <- jointModel(lmefit,coxfit,timeVar="obstime",
+ method="spline-PH-aGH")
> summary(jm)
> ##joint model bayes
> jmb <- jointModelBayes(lmefit,coxfit,timeVar="obstime",
+ baseHaz = "regression-splines")
> summary(jmb)
> ##confidence intervals
> confint(jm)
> confint(jmb)
> xtable(jm)
> xtable(jmb)
> confint2log(jm)
> confint2log(jmb)
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> #####################################
> ## MODELS FOR T1+T2 AND VIRAL LOAD ##
> #####################################
> ##read data
> dades <- read.table("dades_T1T2CV.txt", sep="\t",head=T)
> dades.id <- dades[!duplicated(dades$ID),]
> ##survival model
> coxfit <- coxph(Surv(T1T2,d)~sqrt(CD4N),data=dades.id,x=TRUE)
> ##lme model
> lmefit <- lme(log10(CV)~obstime,random=~1|ID, data=dades)
> ##joint model
> jm <- jointModel(lmefit,coxfit,timeVar="obstime",
+ method="spline-PH-aGH")
> summary(jm)
> ##joint model bayes
> jmb <- jointModelBayes(lmefit,coxfit,timeVar="obstime",
+ baseHaz = "regression-splines")
> summary(jmb)
> ##confidence intervals
> confint(jm)
> confint(jmb)
> xtable(jm)
> xtable(jmb)
> confint2log(jm)
> confint2log(jmb)
